ϳԹԴ

The Renal Research Group

The Renal Research Group has conducted basic research in renal diseases and hypertension since the early seventies. The main objectives have been to explore mechanisms in development of chronic renal failure in rats and mice.

Group picture from 2023, The Renal Research Group
Photo: Group photo, Renal Research Group

Affiliation

About the research group

The Renal Research Group belongs to the with strong links to the Renal Unit at (Helse Bergen). The group is an open forum for clinical and translational kidney research in Bergen and has been directed by Associate Professor Øystein Solberg Eikrem. Traditionally, the Renal Research Group has combined human/animal studies of disease mechanisms and molecular kidney biopsy analyses with epidemiological studies of risk factors of chronic kidney disease.

Senior Scientistsbelong to the group, including Prof. .ʰǴ. and , PhD, direct all clinical and histological Fabry studies together with , PhD.Prof. at ϳԹԴ and (Haugesund Hospital), the winner of the 2017 of our Faculty of Medicine, has a particular focus on epidemiology and on proteomics (e.g. IgA nephropathy). Associate Prof. , the renal pathologist of the Norwegian Kidney Biopsy Registry (NKBR), is instrumental in all studies related to kidney histology, including automated image analysis. Associate Professor and Professor have translational and clinical projects on IgA nephropathy and C3 nephropathy.

Addresses

Mailing address:

Department of Clinical Medicine
The Laboratory Building
Haukeland University Hospital
5021 Bergen
NORWAY

 

Visiting address: 

Department of Clinical Medicine 
The laboratory building, 7th floor
Haukeland University Hospital 
5021 Bergen 

 

Members of the Renal Research Group

Renal Research Group: Translational and Clinical Research Staff

  • Rannveig Skrunes, MD, PhD
  • , MD, PhD, Postdoctoral Fellow
  • Kristin Kampevold Larsen, MD, Nephropathologist
  • Lea Landolt, MD, PhD,Postdoctoral Fellow
  • , PhD, senior Bioengineer
  • , BDS, MSc, PhD,Postdoctoral fellow
  • ,BDS, PhD, Research Bioengineer.
  • , Msc, PhD candidate
  • , MD, PhD candidate
  • , MSc, PhD candidate
  • , MD, PhD candidate
  • , MD, PhD candidate
  • MD , PhD candidate
  • , MSc, PhD candidate
  • , PhD candidate
  • , BDS, PhD, senior Bioengineer.
  • Mariell Rivedal, Medical student,Research student (Forskerlinje)
  • Sigrid Nakken, Medical student,Research student (Forskerlinje)
  • Håvard Mikkelsen, Research student (Forskerlinje)

Renal Research Group: Senior Members

  • , dr. med. and dr. h.c., Professor of Nephrology, Leader of the Renal Research Group
  • , MD, PhD, Associate Professor of Nephrology
  • , MD, PhD, Professor of Nephrology
  • , MD, PhD, Professor of Nephrology
  • , MD, PhD, Professor of Pediatric Nephrology
  • , MD, PhD, Nephropathologist, Associate Professor of Pathology
  • , MD, PhD, Nephrologist, Department of Medicine
  • , MD, PhD,
  • MD, PhD, Professor of Physiology

Laboratories and facilities

Core facilities at K1 and K2:
The have a diverse collection of scientific equipment and highly qualified supporting technical staff. More details.

The renal research group, as a part of the Department of clinical medicine at the Faculty of Medicine, is utilizing the resources of the core facility to contribute to the scientific output of the department. The group also have access to the at K2

Nephrology research laboratories:

  • General laboratory
  • Organ-on-chip technology at the Renal research group:The renal research group groupis one of the first research groups to work with a commercially available kidney-on-chip

  • Morphology lab

Projects

RNASeq in IgA nephropathy progressors and non progressors

A project to establish a platform for omics-related analyses of kidney biopsies of IgA nephropathy.

This project aims to investigate formalin-fixed, paraffin-embedded (FFPE) kidney biopsies from patients with assumed benign IgA nephropathy utilizing mRNA sequencing in conjunction with immunohistochemistry of complement factors (e.g. C3, C4, MAC).
Patients with minimal change nephropathy and membranous nephropathy can be included as comparators. Biopsies will be obtained from the Norwegian Kidney Biopsy Registry (NKBR) and our respective transcriptomic/IHC results will be correlated with histological IgAN classification, clinical & biochemical findings, such as renal outcome, kidney function (eGFR) and proteinuria. The group members of our group had a previous experience with the latter. Key parameters will be also investigated in serum samples of IgAN patients.

New Paper published:

Primary Glomerulo-nephropathies

.

Nephropathology

Collaborative projects with the Department of Pathology - Haukeland University Hospital

The following projects are running in collaboration with the Department of Pathology, Haukeland University Hospital:

 

1. Collaborative projects with the Department of Pathology, Haukeland University Hospital, Bergen
 "Patologi i Vest"): a centre for applied digitization. 

Increasing​g workload and labour shortages constitute a major challenge for pathology departments in the Western Norwegian Health Region. At the same time, digitization is revolutionizing the field of pathology. Never before has so much data been produced in pathology laboratories. Our project will develop methods to transform this data into meaningful clinical information and implement the results in practical applications. One of our focus areas is chronic kidney disease with the 2 sub-projects:

a. Quantification of kidney fibrosis

Any chronic kidney disease will develop fibrosis, an increase of connective tissue, over time. Fibrosis is a key prognostic marker. Quantification of fibrosis is therefore crucial to assess prognosis and to guide therapy.

People: , Hrafn Weishaupt (Computer Scientist), , (Associate Professor)

b. Automatic classification of glomerular lesions

Glomeruli are capillary tufts filtering waste products from the blood and forming urine together with the tubular system. Glomeruli can be affected by a multitude of diseases and show very diverse lesions. Several deep-learning strategies will be evaluated for e.g., the detection, segmentation, clustering, and classification of glomerular structures from biopsy images.

People: Hrafn Weishaupt (Computer Scientist), Justinas Besusparis (Pathologist), Nazanin Mola (PhD candidate), Sabine Leh (Associate Professor)

 

 

2. Polyvinylpyrrolidone deposition disease

Intravenous use of an oral methadone syrup containing PVP K90 has led to PVP deposition in patients with opioid addiction and IVDU, in some patients likely resulting in severe disease and fatal outcomes. The project investigates the pathological and clinical findings of 33 patients with PVP deposition. A specific focus is PVP-related chronic kidney disease.

Funding: Helse Vest PhD grant

People: (PhD candidate), , Friedemann Leh, Heidi Grønseth, ,

Publications:

Kristoffersen, A. H., T. K. Bjanes, S. Jordal, S. Leh, F. Leh and E. Svarstad (2016). "" J Thromb Haemost 14(5): 936-939.

Stalund, I. V., G. N. Riise, F. Leh, T. K. Bjånes, L. Riise, E. Svarstad and S. Leh (2021). "" F1000Res 10: 300.

Leh, F., I. V. Stalund, T. K. Bjånes, C. Ohldieck, E. Svarstad and S. Leh (2021). "" Hum Pathol 116: 102-111.

Stalund, I. V., H. Grønseth, F. P. Reinholt, E. Svarstad, H. P. Marti and S. Leh (2022). "" Clin J Am Soc Nephrol 17(4): 518-526.

 

 

 

3. Complement C5b-9 activation in kidney disease

Complement activation represents a well-described key pathogenic mechanism underlying inflammatory diseases affecting the kidney. In order to learn more about the significance of C5b-9 deposition, we evaluate the expression of C5b-9 in formalin-fixed, paraffin embedded (FFPE) non-neoplastic kidney biopsies with both glomerular, tubulointerstitial and vascular diseases by means of immunohistochemistry and quantitative image analysis.

People: (PhD candidate), Ga Kei Tam, ,

 

 

 

4. Kidney Biopsy Codes for Pathologists KBC

Information gathered in kidney biopsy registries benefits research, teaching and policy-making. Nowadays registries are mainly using locally developed classifications (sometimes with corresponding codes) for registration of pathology diagnoses. Because of the variety in classifications and codes, comparison, exchange or accumulation of data is hampered. Consequently, there is a great need for a more standardized, universally applicable terminology and interoperable coding for kidney biopsy codes. The KBC project aims to provide a complete and structured list of terminology and codes applicable to kidney biopsies.

People: (Belgium), (Norway)

Publications:

Dendooven, A., H. Peetermans, M. Helbert, T. Q. Nguyen, N. Marcussen, M. Nagata, L. Gesualdo, A. Perkowska-Ptasinska, C. Capusa, J. M. Lopez-Gomez, C. Geddes, M. A. Abdul-Hamid, M. Segelmark, R. Yahya, M. Garau, R. Villanueva, A. Dorman, S. Barbour, R. Cornet, H. Hopfer, K. Amann and S. Leh (2021). "." BMC Nephrol 22(1): 193.

Leh, S. and A. Dendooven (2022). "." Clin Kidney J 15(1): 21-30.

Leh, S., Dendooven, A. „“. Nephrologie 17, 376–385 (2022).


Related persons:

Professor, Professor of Nephrology I

+4794030929
Hans-Peter.Marti@uib.no


Associate Professor

Sabine.Leh@uib.no


Key figures:

  • Acronym: PiV (the Norwegian title is "Patologi i Vest")
  • Duration: 2020 – 2024
  • Funding: 20 Mill. NOK.
  • Strategic investment Western Norway Health Authority
Measurement of kidney function

PET-based GFR measurement in animals and humans:
Olav Tenstad

Measurement of GFR in children:
Camilla Tøndel

Birthweights role in GFR and CKD risk:
Bjørn Egil Vikse

Primary Glomerulo-nephropathies

.

Hypertensive Nephropathy

This project focuses on the utilization of newly developed technology for transcriptomic analysis of archival kidney biopsies and investigates which molecular features of HN increase biopsy accuracy and/or can be recovered in serum and urine specimens. Then, statistical machine learning methods will be developed to integrate these omics-based findings with routine clinical and laboratory patient features to define diagnostic and/or prognostic panels. Individual panel factors will also serve as novel drug targets for the identification of drugs that we can repurpose to treat HN. We will evaluate the biological effect of these drugs in vitro using the new kidney-on-chip technology, which we will refine to better simulate HN. We will further investigate the drugs with the best in vitro effect for their capability to attenuate the progression of HN in silico using pharmacometrics disease progression modelling. Finally, we will design a clinical trial that will begin after this project.

This project will deliver patient-tailored management of HN by improving the accuracy of renal biopsy, developing a non-invasive diagnostic/prognostic HN test allowing early diagnosis and sequential disease monitoring of disease course, and by identifying novel medical therapy.

Fabry’s disease

Three subprojects are running on Fabrys disease:

Observational follow-up studies on Fabry's disease:

Fabry register  (CRISTIN)

Staff:

Camilla Tøndel, Rannveig Skrunes, Sabine Leh and Einar Svarstad

Funding:

Details of funding are here 

Publications:

  1. Burlina A, Brand E, Hughes D, Kantola I, Krӓmer J, Nowak A, Tøndel C, Wanner C, Spada M. An expert consensus on the recommendations for the use of biomarkers in Fabry disease. Mol Genet Metab. 2023 Jun;139(2):107585. doi: 10.1016/j.ymgme.2023.107585. Epub 2023 Apr 17. PMID: 37207471.
  2. Najafian B, Silvestroni A, Sokolovskiy A, Tøndel C, Svarstad E, Obrisca B, Ismail G, Holida MD, Mauer M. A novel unbiased method reveals progressive podocyte globotriaosylceramide accumulation and loss with age in females with Fabry disease. Kidney Int. 2022 Jul;102(1):173-182. doi: 10.1016/j.kint.2022.03.023. Epub 2022 Apr 26. PMID: 35483528; PMCID: PMC9233139.
  3. Najafian B, Tøndel C, Svarstad E, Gubler MC, Oliveira JP, Mauer M. Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss. J Am Soc Nephrol. 2020 Apr;31(4):865-875. doi: 10.1681/ASN.2019050497. Epub 2020 Mar 3. PMID: 32127409; PMCID: PMC7191924.
  4. Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ. European expert consensus statement on therapeutic goals in Fabry disease. Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12. PMID: 30017653.
  5. Spada M, Baron R, Elliott PM, Falissard B, Hilz MJ, Monserrat L, Tøndel C, Tylki-Szymańska A, Wanner C, Germain DP. The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts. Mol Genet Metab. 2019 Mar;126(3):212-223. doi: 10.1016/j.ymgme.2018.04.007. Epub 2018 Apr 26. PMID: 29785937.
  6. Svarstad E, Leh S, Skrunes R, Kampevold Larsen K, Eikrem Ø, Tøndel C. Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid Deposits. Nephron. 2018;138(1):13-21. doi: 10.1159/000479751. Epub 2017 Aug 26. PMID: 28848191.
  7. Skrunes R, Tøndel C, Leh S, Larsen KK, Houge G, Davidsen ES, Hollak C, van Kuilenburg ABP, Vaz FM, Svarstad E. Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1470-1479. doi: 10.2215/CJN.01820217. Epub 2017 Jun 16. PMID: 28625968; PMCID: PMC5586567.
  8. Suntjens E, Dreschler WA, Hess-Erga J, Skrunes R, Wijburg FA, Linthorst GE, Tøndel C, Biegstraaten M. Hearing loss in children with Fabry disease. J Inherit Metab Dis. 2017 Sep;40(5):725-731. doi: 10.1007/s10545-017-0051-5. Epub 2017 May 31. PMID: 28567540; PMCID: PMC5579138.
  9. Eikrem Ø, Skrunes R, Tøndel C, Leh S, Houge G, Svarstad E, Marti HP. Pathomechanisms of renal Fabry disease. Cell Tissue Res. 2017 Jul;369(1):53-62. doi: 10.1007/s00441-017-2609-9. Epub 2017 Apr 12. PMID: 28401309.
  10. Schiffmann R, Hughes DA, Linthorst GE, Ortiz A, Svarstad E, Warnock DG, West ML, Wanner C; Conference Participants. Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Kidney Int. 2017 Feb;91(2):284-293. doi: 10.1016/j.kint.2016.10.004. Epub 2016 Dec 18. PMID: 27998644.
  11. Skrunes R, Svarstad E, Kampevold Larsen K, Leh S, Tøndel C. Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients. Nephrol Dial Transplant. 2017 May 1;32(5):807-813. doi: 10.1093/ndt/gfw094. PMID: 27190352.
  12. Najafian B, Tøndel C, Svarstad E, Sokolovkiy A, Smith K, Mauer M. One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease. PLoS One. 2016 Apr 15;11(4):e0152812. doi: 10.1371/journal.pone.0152812. PMID: 27081853; PMCID: PMC4833322.
  13. Biegstraaten M, Arngrímsson R, Barbey F, Boks L, Cecchi F, Deegan PB, Feldt-Rasmussen U, Geberhiwot T, Germain DP, Hendriksz C, Hughes DA, Kantola I, Karabul N, Lavery C, Linthorst GE, Mehta A, van de Mheen E, Oliveira JP, Parini R, Ramaswami U, Rudnicki M, Serra A, Sommer C, Sunder-Plassmann G, Svarstad E, Sweeb A, Terryn W, Tylki-Szymanska A, Tøndel C, Vujkovac B, Weidemann F, Wijburg FA, Woolfson P, Hollak CE. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document. Orphanet J Rare Dis. 2015 Mar 27;10:36. doi: 10.1186/s13023-015-0253-6. PMID: 25885911; PMCID: PMC4383065.
  14. Tøndel C, Kanai T, Larsen KK, Ito S, Politei JM, Warnock DG, Svarstad E. Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria. Nephron. 2015;129(1):16-21. doi: 10.1159/000369309. Epub 2014 Dec 17. PMID: 25531941.
  15. Mauer M, Glynn E, Svarstad E, Tøndel C, Gubler MC, West M, Sokolovskiy A, Whitley C, Najafian B. Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease. PLoS One. 2014 Nov 11;9(11):e112188. doi: 10.1371/journal.pone.0112188. PMID: 25386848; PMCID: PMC4227696.
  16. van der Tol L, Cassiman D, Houge G, Janssen MC, Lachmann RH, Linthorst GE, Ramaswami U, Sommer C, Tøndel C, West ML, Weidemann F, Wijburg FA, Svarstad E, Hollak CE, Biegstraaten M. Uncertain diagnosis of fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up. JIMD Rep. 2014;17:83-90. doi: 10.1007/8904_2014_342. Epub 2014 Sep 16. PMID: 25224312; PMCID: PMC4241201.
  17. van der Tol L, Svarstad E, Ortiz A, Tøndel C, Oliveira JP, Vogt L, Waldek S, Hughes DA, Lachmann RH, Terryn W, Hollak CE, Florquin S, van den Bergh Weerman MA, Wanner C, West ML, Biegstraaten M, Linthorst GE. Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis. Mol Genet Metab. 2015 Feb;114(2):242-7. doi: 10.1016/j.ymgme.2014.08.007. Epub 2014 Aug 20. PMID: 25187469.
  18. Linthorst GE, Burlina AP, Cecchi F, Cox TM, Fletcher JM, Feldt-Rasmussen U, Giugliani R, Hollak CE, Houge G, Hughes D, Kantola I, Lachmann R, Lopez M, Ortiz A, Parini R, Rivera A, Rolfs A, Ramaswami U, Svarstad E, Tondel C, Tylki-Szymanska A, Vujkovac B, Waldek S, West M, Weidemann F, Mehta A. Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage. JIMD Rep. 2013;8:51-6. doi: 10.1007/8904_2012_160. Epub 2012 Jul 14. PMID: 23430520; PMCID: PMC3565660.
  19. Tøndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, Svarstad E. Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol. 2013 Jan;24(1):137-48. doi: 10.1681/ASN.2012030316. PMID: 23274955; PMCID: PMC3537211.
  20. Bertelsen AK, Tøndel C, Krohn J, Bull N, Aarseth J, Houge G, Mellgren SI, Vedeler CA. Small fibre neuropathy in Fabry disease. J Neurol. 2013 Mar;260(3):917-9. doi: 10.1007/s00415-012-6800-3. Epub 2012 Dec 21. PMID: 23263
  21. Houge G, Tøndel C, Kaarbøe O, Hirth A, Bostad L, Svarstad E. Fabry or not Fabry--a question of ascertainment. Eur J Hum Genet. 2011 Nov;19(11):1111. doi: 10.1038/ejhg.2011.87. Epub 2011 May 18. PMID: 21587323; PMCID: PMC3198147.
  22. Najafian B, Svarstad E, Bostad L, Gubler MC, Tøndel C, Whitley C, Mauer M. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int. 2011 Mar;79(6):663-670. doi: 10.1038/ki.2010.484. Epub 2010 Dec 15. PMID: 21160462; PMCID: PMC3640823.
  23. Guest JF, Jenssen T, Houge G, Aaseboe W, Tøndel C, Svarstad E. Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion. Eur J Clin Invest. 2010 Dec;40(12):1104-12. doi: 10.1111/j.1365-2362.2010.02363.x. Epub 2010 Sep 9. PMID: 21070219.
  24. Tøndel C, Ramaswami U, Aakre KM, Wijburg F, Bouwman M, Svarstad E. Monitoring renal function in children with Fabry disease: comparisons of measured and creatinine-based estimated glomerular filtration rate. Nephrol Dial Transplant. 2010 May;25(5):1507-13. doi: 10.1093/ndt/gfp658. Epub 2009 Dec 27. PMID: 20038520.
  25. Aakre KM, Tøndel C, Brun A, Svarstad E. The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function. Clin Nephrol. 2009 Feb;71(2):118-24. doi: 10.5414/cnp71118. PMID: 19203503.
  26. Tøndel C, Bostad L, Hirth A, Svarstad E. Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis. 2008 May;51(5):767-76. doi: 10.1053/j.ajkd.2007.12.032. Epub 2008 Mar 20. Erratum in: Am J Kidney Dis. 2009 Mar;53(3):567. PMID: 18436087.
  27. Svarstad E, Bostad L, Kaarbøe O, Houge G, Tøndel C, Lyngdal PT, Iversen BM. Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease. Clin Nephrol. 2005 May;63(5):394-401. doi: 10.5414/cnp63394. PMID: 15909601.
  28. Tøndel C, Laegreid LM, Hirth A, Houge G, Månsson JE, Søvik O. Intravenøs enzymsubstitusjonsbehandling ved Fabrys sykdom hos barn [Intravenous enzyme substitution therapy in children with Fabry's disease]. Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3388-90. Norwegian. PMID: 14713976.

 

Clinical interventional studies Fabry's disease:
Staff:

Camilla Tøndel, Rannveig Skrunes and Øystein Eikrem

Funding:

Publications:

  1. Hopkin RJ, Cabrera GH, Jefferies JL, Yang M, Ponce E, Brand E, Feldt-Rasmussen U, Germain DP, Guffon N, Jovanovic A, Kantola I, Karaa A, Martins AM, Tøndel C, Wilcox WR, Yoo HW, Burlina AP, Mauer M. Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry Registry. Mol Genet Metab. 2023 Feb;138(2):106967. doi: 10.1016/j.ymgme.2022.106967. Epub 2022 Nov 30. PMID: 36709533.
  2. Tøndel C, Thurberg BL, DasMahapatra P, Lyn N, Maski M, Batista JL, George K, Patel H, Hariri A. Clinical relevance of globotriaosylceramide accumulation in Fabry disease and the effect of agalsidase beta in affected tissues. Mol Genet Metab. 2022 Dec;137(4):328-341. doi: 10.1016/j.ymgme.2022.10.005. Epub 2022 Oct 29. PMID: 36334424.
  3. van der Veen SJ, Körver S, Hirsch A, Hollak CEM, Wijburg FA, Brands MM, Tøndel C, van Kuilenburg ABP, Langeveld M. Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression. Mol Genet Metab. 2022 Feb;135(2):163-169. doi: 10.1016/j.ymgme.2021.12.004. Epub 2021 Dec 17. PMID: 35033446.
  4. Moreno-Martinez D, Aguiar P, Auray-Blais C, Beck M, Bichet DG, Burlina A, Cole D, Elliott P, Feldt-Rasmussen U, Feriozzi S, Fletcher J, Giugliani R, Jovanovic A, Kampmann C, Langeveld M, Lidove O, Linhart A, Mauer M, Moon JC, Muir A, Nowak A, Oliveira JP, Ortiz A, Pintos-Morell G, Politei J, Rozenfeld P, Schiffmann R, Svarstad E, Talbot AS, Thomas M, Tøndel C, Warnock D, West ML, Hughes DA. Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus. Mol Genet Metab. 2021 Apr;132(4):234-243. doi: 10.1016/j.ymgme.2021.02.001. Epub 2021 Feb 20. PMID: 33642210.
  5. Ramaswami U, Bichet DG, Clarke LA, Dostalova G, Fainboim A, Fellgiebel A, Forcelini CM, An Haack K, Hopkin RJ, Mauer M, Najafian B, Scott CR, Shankar SP, Thurberg BL, Tøndel C, Tylki-Szymanska A, Bénichou B, Wijburg FA. Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial. Mol Genet Metab. 2019 May;127(1):86-94. doi: 10.1016/j.ymgme.2019.03.010. Epub 2019 Apr 3. PMID: 30987917.
  6. Wijburg FA, Bénichou B, Bichet DG, Clarke LA, Dostalova G, Fainboim A, Fellgiebel A, Forcelini C, An Haack K, Hopkin RJ, Mauer M, Najafian B, Scott CR, Shankar SP, Thurberg BL, Tøndel C, Tylki-Szymańska A, Ramaswami U. Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial. PLoS One. 2015 May 8;10(5):e0124987. doi: 10.1371/journal.pone.0124987. PMID: 25955246; PMCID: PMC4425695.
     

Translational studies Fabry's disease:
Different subprojects included (CRISTIN links): 

 

  • PB-102-F60  
  • LPS15919 -
  • Clinical Trial: A randomized, open-label study to evaluate glycosphingolipid (GL-3) removal and clinical effects of switching treatment to agalsidase beta (Fabrazyme) versus continuing treatment with agalsidase alfa (Replagal) in male patients with Fabry disease
  • Lucerastat-long-term treatment-ID-069A302
  • MODIFY - Placebo-controlled study with oral Lucerastat monotherapy in Fabry disease
  • Phase 1/2 gene therapy study with AVV vector in Fabry disease
  • PB-102-F50:  A phase 3 open-label switch study to assess the safety, efficacy, and pharmacokinetics of pegunigalsidase alfa 2 mg/kg administered intravenously every 4 weeks for 52 weeks in patients with Fabry disease currently treated with enzyme replacement therapy. BRIGHT
  • PB-102-F51 Long-term treatment with Unigal every 4 weeks
  • Protalix PB-102-F30 An open-label study of the safety and efficacy of PRX-102 in patients with Fabry disease treated with Replagal (agalsidase alfa)
  • PB-102-F20 - A randomized, double-blind, active-controlled study of the safety and efficacy of PRX-102 compared with agalsidase beta on renal function in patients with Fabry disease previously treated with agalsidase beta
  • Fabry register  
  • Venglustat for neuropathic and abdominal pain in men and women with Fabry disease - EFC17045

Staff:

Hans-Peter Marti, Øystein Eikrem, Jessica Furriol and Philipp Strauss

Funding:

Publications:

  1. Lillås BS, Tøndel C, Melsom T, Eriksen BO, Marti HP, Vikse BE. Response to Birth Weight and Renal Functional Reserve in Adults. Kidney Int Rep. 2023 Jun 17;8(8):1700-1701. doi: 10.1016/j.ekir.2023.06.012. PMID: 37547517; PMCID: PMC10403668.
  2. Lillås BS, Tøndel C, Melsom T, Eriksen BO, Marti HP, Vikse BE. Renal Functional Response-Association With Birth Weight and Kidney Volume. Kidney Int Rep. 2023 Feb 20;8(5):1034-1042. doi: 10.1016/j.ekir.2023.02.1079. PMID: 37180504; PMCID: PMC10166784.
  3. Lillås BS, Tøndel C, Aßmus J, Vikse BE. Low birthweight is associated with lower glomerular filtration rate in middle-aged mainly healthy women. Nephrol Dial Transplant. 2021 Dec 31;37(1):92-99. doi: 10.1093/ndt/gfaa306. PMID: 33313893; PMCID: PMC8719610.
  4. Gjerde A, Skrunes R, Reisæter AV, Marti HP, Vikse BE. Familial Contributions to the Association Between Low Birth Weight and Risk of CKD in Adult Life. Kidney Int Rep. 2021 May 30;6(8):2151-2158. doi: 10.1016/j.ekir.2021.05.032. PMID: 34386664; PMCID: PMC8343716.
  5. Gjerde A, Reisæter AV, Skrunes R, Marti HP, Vikse BE. Intrauterine Growth Restriction and Risk of Diverse Forms of Kidney Disease during the First 50 Years of Life. Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1413-1423. doi: 10.2215/CJN.04080320. Epub 2020 Aug 17. PMID: 32816833; PMCID: PMC7536758.
  6. Gjerde A, Lillås BS, Marti HP, Reisæter AV, Vikse BE. Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life. Nephrol Dial Transplant. 2020 Jul 1;35(7):1157-1163. doi: 10.1093/ndt/gfaa001. PMID: 32040151; PMCID: PMC7417009.
  7. Lillås BS, Tøndel C, Gjerde A, Vikse BE. Measurement of renal functional response using iohexol clearance-a study of different outpatient procedures. Clin Kidney J. 2019 Nov 26;14(1):181-188. doi: 10.1093/ckj/sfz167. PMID: 33564417; PMCID: PMC7857819.
     

 

Leaders:


Professor, Head of Teaching

camilla.tondel@uib.no


Associate Professor

oystein.eikrem@uib.no


Professor, Professor of Nephrology I

+4794030929
Hans-Peter.Marti@uib.no

Kidney Cancer

Different subProjects related to kidney cancer:

Prognostic biomarkers in human renal cancer:
Hans-Peter Marti, Øystein Eikrem, Jessica Furriol and Christian Beisland. Helse Vest grant.

Caveolin expression in human renal cancer:
Jessica Furriol

Hyperion - Image mass cytometry tissue analyses:
Responsible people: Tarig Osman and Tony Chen

Image Mass Cytometry (Hyprion) identification of kidney cancer biomarkers
Pilot Study: Hyperion Imaging System is a reliable tool for simultaneous detection of multiple markers in archival kidney biopsies.

The HyperionTM Imaging System is a high-parameter imaging system that enables the simultaneous detection of
up to 40 protein markers using metal-tagged antibodies. It allows measurements of antigen
abundances at sub-cellular resolution and exploration of cell-cell interactions and can potentially
increase the diagnostic and pathophysiological yield of archival biopsies.
This project aimed to investigate this technique's applicability on archival formalin-fixed paraffin-embedded (FFPE) kidney biopsies.

Based on our first pilot study, further processing and data analysis would be needed to enable the exploration of the cell-cell interactions.


Interventional animal studies (Axl inhibitor)):
Lea Landolt
 

Various collaborative projects

We are collaborating on different multidisciplinary projects as follows: 

Manifestations and pathogeneisis of Sjögren’s syndrome:
Kathrine Skarstein, Hanne Borge, Hans-Peter Marti.

SGLT2 expression in diabetes mellitus after kidney transplantation:
Jessica Furriol, Hans-Peter Marti.

Role of peroxidasin CKD:
Hans-Peter Marti and Tony Chen.

A pilot study of the application of microbubbles to mouse kidneys:
Øystein Eikrem.

Nutritional assessment of CKD, HD and transplant patients:
Hans-Peter Marti.

Publications

Published research by group members






 











2024
  1. Marti HP, Pavía López AA, Schwartzmann P.  Curr Med Res Opin. 2024;40(sup1):55-62. doi: 10.1080/03007995.2024.2317433. Epub 2024 Apr 10.
  2. Rivedal M, Mikkelsen H, Marti HP, Liu L, Kiryluk K, Knoop T, Bjørneklett R, Haaskjold YL, Furriol J, Leh S, Paunas F, Bábíčková J, Scherer A, Serre C, Eikrem O, Strauss P.  Kidney Int. 2024 Apr;105(4):717-730. doi: 10.1016/j.kint.2023.12.010. Epub 2023 Dec 26.
  3. Sekulic M, Batal I, Kudose S, Santoriello D, Stokes MB, Jim B, Marti HP, Eikrem Ø, Radhakrishnan J, D'Agati VD, Markowitz GS. . Kidney Int Rep. 2023 Nov 7;9(2):410-422. doi: 10.1016/j.ekir.2023.10.033. eCollection 2024 Feb.
  4. Samodova D, Hoel A, Hansen TH, Clausen L, Telléus GK, Marti HP, Pedersen O, Støving RK, Deshmukh AS.  Metabolism. 2024 Mar;152:155760. doi: 10.1016/j.metabol.2023.155760. Epub 2023 Dec 15.
  5. Rivedal M, Haaskjold YL, Eikrem Ø, Bjørneklett R, Marti HP, Knoop T.  BMC Nephrol. 2024 Jan 29;25(1):42. doi: 10.1186/s12882-024-03481-6.
  6. Smerkous D, Mauer M, Tøndel C, Svarstad E, Gubler MC, Nelson RG, Oliveira JP, Sargolzaeiaval F, Najafian B.  Kidney Int. 2024 Jan;105(1):165-176. doi: 10.1016/j.kint.2023.09.011. Epub 2023 Sep 27. 
2023
  1. Rivedal M, Haaskjold YL, Berge H, Knoop T. Kidney Med. 2023 Aug 9;5(10):100709. doi: 10.1016/j.xkme.2023.100709.
  2. Elsaid HOA, Rivedal M, Skandalou E, Svarstad E, Tøndel C, Birkeland E, Eikrem Ø, Babickova J, Marti HP, Furriol J. J Transl Med. 2023 Sep 5;21(1):591. doi: 10.1186/s12967-023-04475-y.
  3. Kristiansen CK, Furriol J, Chen A, Sullivan GJ, Bindoff LA, Liang KX. FASEB J. 2023 Sep;37(9):e23139. doi: 10.1096/fj.202300650RR.PMID: 37584631
  4. Kipp A, Marti HP, Babickova J, Nakken S, Leh S, Halden TAS, Jenssen T, Vikse BE, Åsberg A, Spagnoli G, Furriol J.  BMC Nephrol. 2023 Aug 25;24(1):254. doi: 10.1186/s12882-023-03294-z.
  5. O'Keeffe M, Oterhals Å, Weishaupt H, Leh S, Ulvik A, Ueland PM, Halstensen A, Marti HP, Gudbrandsen OA.  Eur J Nutr. 2023 Aug 7. doi: 10.1007/s00394-023-03227-4.
  6. Lillås BS, Tøndel C, Melsom T, Eriksen BO, Marti HP, Vikse BE. Kidney Int Rep. 2023 Jun 17;8(8):1700-1701. doi: 10.1016/j.ekir.2023.06.012.
  7. Malicki S, Książek M, Sochaj Gregorczyk A, Kamińska M, Golda A, Chruścicka B, Mizgalska D, Potempa J, Marti HP, Kozieł J, Wieczorek M, Pieczykolan J, Mydel P, Dubin G.  J Biol Chem. 2023 Aug;299(8):104889. doi: 10.1016/j.jbc.2023.104889.
  8. Åsberg A, Hovd M, Kjellevold SA, Stenehjem AE, Wien TN, Broch LU, Reier-Nielsen M, Qvale TH, Marti HP, Heldal K, Bitter J, Hagelsteen Kvien E, Vaage JT, Lund-Johansen F, Midtvedt K.  Transplantation. 2023 Jul 27. doi: 10.1097/TP.0000000000004732.
  9. Delaleu N, Marti HP, Strauss P, Sekulic M, Osman T, Tøndel C, Skrunes R, Leh S, Svarstad E, Nowak A, Gaspert A, Rusu E, Kwee I, Rinaldi A, Flatberg A, Eikrem O. Kidney Int. 2023 Jul 5:S0085-2538(23)00487-8. doi: 10.1016/j.kint.2023.06.029.
  10. Braun F, Abed A, Sellung D, Rogg M, Woidy M, Eikrem O, Wanner N, Gambardella J, Laufer SD, Haas F, Wong MN, Dumoulin B, Rischke P, Mühlig A, Sachs W, von Cossel K, Schulz K, Muschol N, Gersting SW, Muntau AC, Kretz O, Hahn O, Rinschen MM, Mauer M, Bork T, Grahammer F, Liang W, Eierhoff T, Römer W, Hansen A, Meyer-Schwesinger C, Iaccarino G, Tøndel C, Marti HP, Najafian B, Puelles VG, Schell C, Huber TB. J Clin Invest. 2023 Jun 1;133(11):e157782. doi: 10.1172/JCI157782.
  11. Haaskjold YL, Lura NG, Bjørneklett R, Bostad L, Bostad LS, Knoop T. Nephrol Dial Transplant. 2023 May 4;38(5):1183-1191. doi: 10.1093/ndt/gfac225.
  12. Lillås BS, Tøndel C, Melsom T, Eriksen BO, Marti HP, Vikse BE. Kidney Int Rep. 2023 Feb 20;8(5):1034-1042. doi: 10.1016/j.ekir.2023.02.1079.
  13. Gjerstad AC, Skrunes R, Tøndel C, Åsberg A, Leh S, Klingenberg C, Døllner H, Hammarstrøm C, Bjerre AK. Pediatr Nephrol. 2023 Apr;38(4):1249-1256. doi: 10.1007/s00467-022-05706-y.
  14. Dahl H, Meyer K, Sandnes K, Welland NL, Arnesen I, Marti HP, Dierkes J, Lysne V. PLoS One. 2023 Feb 1;18(2):e0269436. doi: 10.1371/journal.pone.0269436.
  15. Krendel M, Leh S, Garone ME, Edwards-Richards A, Lin JJ, Brackman D, Knappskog P, Mikhailov A. Pediatr Nephrol. 2023 Feb;38(2):439-449. doi: 10.1007/s00467-022-05634-x.
  16. Eikrem Ø, Lillefosse B, Delaleu N, Strauss P, Osman T, Vikse BE, Debiec H, Ronco P, Sekulic M, Koch E, Furriol J, Leh SM, Marti HP. Biomedicines. 2023 Jan 16;11(1):226. doi: 10.3390/biomedicines11010226.
  17. Mikkelsen H, Vikse BE, Eikrem O, Scherer A, Finne K, Osman T, Marti HP. Hypertens Res. 2023 Jan;46(1):144-156. doi: 10.1038/s41440-022-01066-0.
  18. Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart A, Hughes DA, Hopkin RJ, Tøndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V, Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG.  J Med Genet. 2023 Nov 8:jmg-2023-109445. doi: 10.1136/jmg-2023-109445. Online ahead of print.PMID: 37940383
  19. Linhart A, Dostálová G, Nicholls K, West ML, Tøndel C, Jovanovic A, Giraldo P, Vujkovac B, Geberhiwot T, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Hughes D.  Orphanet J Rare Dis. 2023 Oct 21;18(1):332. doi: 10.1186/s13023-023-02937-6.
  20. Smerkous D, Mauer M, Tøndel C, Svarstad E, Gubler MC, Nelson RG, Oliveira JP, Sargolzaeiaval F, Najafian B.  Kidney Int. 2024 Jan;105(1):165-176. doi: 10.1016/j.kint.2023.09.011. Epub 2023 Sep 27.
  21. Bichet DG, Hopkin RJ, Aguiar P, Allam SR, Chien YH, Giugliani R, Kallish S, Kineen S, Lidove O, Niu DM, Olivotto I, Politei J, Rakoski P, Torra R, Tøndel C, Hughes DA.  Front Med (Lausanne). 2023 Sep 1;10:1220637. doi: 10.3389/fmed.2023.1220637. eCollection 2023.
  22. Bradley JS, Makieieva N, Tøndel C, Roilides E, Kelly MS, Patel M, Vaddady P, Maniar A, Zhang Y, Paschke A, Chen LF.  J Clin Pharmacol. 2023 Dec;63(12):1387-1397. doi: 10.1002/jcph.2334. Epub 2023 Sep 2.
  23. Bansal A, Trieu MC, Mohn KGI, Madsen A, Olofsson JS, Sandnes HH, Sævik M, Søyland H, Hansen L, Onyango TB, Tøndel C, Brokstad KA; Bergen COVID-19 research group; Syre H, Riis ÅG, Langeland N, Cox RJ.  Front Public Health. 2023 Jul 21;11:1164326. doi: 10.3389/fpubh.2023.1164326. eCollection 2023.
  24. Salvador CL, Flemmen PTK, Tøndel C, Bliksrud YT, Tsui EFF, Brun A, Bjerre A, Mørkrid L.  Mol Genet Metab. 2023 Nov;140(3):107649. doi: 10.1016/j.ymgme.2023.107649. Epub 2023 Jul 5.
  25. Burlina A, Brand E, Hughes D, Kantola I, Krӓmer J, Nowak A, Tøndel C, Wanner C, Spada M.  Mol Genet Metab. 2023 Jun;139(2):107585. doi: 10.1016/j.ymgme.2023.107585. Epub 2023 Apr 17.
  26. Hopkin RJ, Cabrera GH, Jefferies JL, Yang M, Ponce E, Brand E, Feldt-Rasmussen U, Germain DP, Guffon N, Jovanovic A, Kantola I, Karaa A, Martins AM, Tøndel C, Wilcox WR, Yoo HW, Burlina AP, Mauer M.  Mol Genet Metab. 2023 Feb;138(2):106967. doi: 10.1016/j.ymgme.2022.106967. Epub 2022 Nov 30.
  27. Hansen L, Brokstad KA, Bansal A, Zhou F, Bredholt G, Onyango TB, Sandnes HH, Elyanow R, Madsen A, Trieu MC, Sævik M, Søyland H, Olofsson JS, Vahokoski J, Ertesvåg NU, Fjelltveit EB, Shafiani S, Tøndel C, Chapman H, Kaplan I, Mohn KGI, Langeland N, Cox RJ.  Vaccine X. 2023 Apr;13:100262. doi: 10.1016/j.jvacx.2023.100262. Epub 2023 Jan 10.
  28. Fjelltveit EB, Blomberg B, Kuwelker K, Zhou F, Onyango TB, Brokstad KA, Elyanow R, Kaplan IM, Tøndel C, Mohn KGI, Özgümüş T, Cox RJ, Langeland N; Bergen COVID-19 Research Group.  Clin Infect Dis. 2023 Feb 8;76(3):e60-e70. doi: 10.1093/cid/ciac655.
  29. Smeets NJL, Teunissen EMM, van der Velden K, van der Burgh MJP, Linders DE, Teesselink E, Moes DAR, Tøndel C, Ter Heine R, van Heijst A, Schreuder MF, de Wildt SN.  Pediatr Nephrol. 2023 Apr;38(4):1087-1097. doi: 10.1007/s00467-022-05651-w. Epub 2022 Aug 2.
2022
  1. Dahl H, Rosendahl-Riise H, Marti HP, Dierkes J. Curr Dev Nutr. 2022 Dec 22;7(1):100014. doi: 10.1016/j.cdnut.2022.100014.
  2. Elsaid HOA, Tjeldnes H, Rivedal M, Serre C, Eikrem Ø, Svarstad E, Tøndel C, Marti HP, Furriol J, Babickova J. Int J Mol Sci. 2022 Dec 26;24(1):358. doi: 10.3390/ijms24010358.
  3. Haaskjold YL, Knoop T.  Tidsskr Nor Laegeforen. 2022 Dec 12;142(18). doi: 10.4045/tidsskr.22.0740.
  4. Haaskjold YL, Knoop T. Tidsskr Nor Laegeforen. 2022 Nov 7;142(16). doi: 10.4045/tidsskr.22.0146.
  5. Vildmyren I, Oterhals Å, Leh S, Samuelsen TA, Halstensen A, Marti HP, Gudbrandsen OA. Food Nutr Res. 2022 Oct 11;66. doi: 10.29219/fnr.v66.8708
  6. Binder V, Chruścicka-Smaga B, Bergum B, Jaisson S, Gillery P, Sivertsen J, Hervig T, Kaminska M, Tilvawala R, Nemmara VV, Thompson PR, Potempa J, Marti HP, Mydel P. J Am Soc Nephrol. 2022 Oct;33(10):1841-1856. doi: 10.1681/ASN.2022010013.
  7. Dahl H, Sandblost SRT, Welland NL, Sandnes K, Sekse I, Sæle K, Marti HP, Holst L, Dierkes J. J Ren Nutr. 2022 Sep;32(5):520-528. doi: 10.1053/j.jrn.2021.10.008.
  8. Strauss P, Rivedal M, Scherer A, Eikrem Ø, Nakken S, Beisland C, Bostad L, Flatberg A, Skandalou E, Beisvåg V, Furriol J, Marti HP. Sci Rep. 2022 Aug 5;12(1):13503. doi: 10.1038/s41598-022-17755-2.
  9. Apeland T, Ushakova A, Mansoor MA, Furriol J, Jonsson G, Marti HP. Free Radic Biol Med. 2022 Aug 1;188:62-70. doi: 10.1016/j.freeradbiomed.2022.06.224.
  10. Malicki S, Pucelik B, Żyła E, Benedyk-Machaczka M, Gałan W, Golda A, Sochaj-Gregorczyk A, Kamińska M, Encarnação JC, Chruścicka B, Marti HP, Chen TJ, Magiera-Mularz K, Zięba B, Holak TA, Dąbrowski JM, Czarna A, Kozieł J, Mydel P, Dubin G. Pharmaceuticals (Basel). 2022 Jun 1;15(6):697. doi: 10.3390/ph15060697.
  11. Elsaid HOA, Furriol J, Blomqvist M, Diswall M, Leh S, Gharbi N, Anonsen JH, Babickova J, Tøndel C, Svarstad E, Marti HP, Krause M. Mol Genet Metab Rep. 2022 Feb 17;31:100851. doi: 10.1016/j.ymgmr.2022.100851.
  12. Dahl H, Warz SI, Welland NL, Arnesen I, Marti HP, Dierkes J. J Ren Care. 2022 Jun;48(2):112-118. doi: 10.1111/jorc.12374.
  13. Landolt L, Spagnoli GC, Hertig A, Brocheriou I, Marti HP. Nephrol Dial Transplant. 2022 May 25;37(6):1024-1032. doi: 10.1093/ndt/gfaa301.
  14. Stalund IV, Grønseth H, Reinholt FP, Svarstad E, Marti HP, Leh S. Clin J Am Soc Nephrol. 2022 Apr;17(4):518-526. doi: 10.2215/CJN.13681021.
  15. Paunas FTI, Finne K, Leh S, Marti HP, Berven F, Vikse BE. BMC Nephrol. 2022 Mar 24;23(1):118. doi: 10.1186/s12882-022-02736-4.
  16. Schem BC, Pfeffer F, Ott MA, Wiig JN, Sletteskog N, Frøystein T, Myklebust MP, Leh S, Dahl O, Mella O.  Cancers (Basel). 2022 Jan 29;14(3):705. doi: 10.3390/cancers14030705
  17. Haaskjold YL, Bjørneklett R, Bostad L, Bostad LS, Lura NG, Knoop T. BMC Nephrol. 2022 Jan 11;23(1):26. doi: 10.1186/s12882-021-02653-y.
  18. Tøndel C, Thurberg BL, DasMahapatra P, Lyn N, Maski M, Batista JL, George K, Patel H, Hariri A.  Mol Genet Metab. 2022 Dec;137(4):328-341. doi: 10.1016/j.ymgme.2022.10.005. Epub 2022 Oct 29.
  19. Syre H, Obreque MEB, Dalen I, Riis ÅG, Berg Å, Löhr IH, Sundal J, Kleppe LK, Vadla MS, Lenning OB, Olofsson JS, Mohn KG, Tøndel C, Blomberg B, Trieu MC, Langeland N, Cox RJ. . Viruses. 2022 Oct 5;14(10):2196. doi: 10.3390/v14102196.
  20. Gjerstad AC, Skrunes R, Tøndel C, Åsberg A, Leh S, Klingenberg C, Døllner H, Hammarstrøm C, Bjerre AK.  Pediatr Nephrol. 2023 Apr;38(4):1249-1256. doi: 10.1007/s00467-022-05706-y. Epub 2022 Aug 22.
  21. Smeets NJL, Teunissen EMM, van der Velden K, van der Burgh MJP, Linders DE, Teesselink E, Moes DAR, Tøndel C, Ter Heine R, van Heijst A, Schreuder MF, de Wildt SN.  Pediatr Nephrol. 2023 Apr;38(4):1087-1097. doi: 10.1007/s00467-022-05651-w. Epub 2022 Aug 2.
  22. Najafian B, Silvestroni A, Sokolovskiy A, Tøndel C, Svarstad E, Obrisca B, Ismail G, Holida MD, Mauer M.  Kidney Int. 2022 Jul;102(1):173-182. doi: 10.1016/j.kint.2022.03.023. Epub 2022 Apr 26.
  23. Tøndel C, Marti HP. . Clin Kidney J. 2021 Nov 11;15(2):183-185. doi: 10.1093/ckj/sfab223. eCollection 2022 Feb.
2021
  1. Tøndel C, Marti HP. Clin Kidney J. 2021 Nov 11;15(2):183-185. doi: 10.1093/ckj/sfab223.
  2. Leh S, Dendooven A. Clin Kidney J. 2021 Jul 23;15(1):21-30. doi: 10.1093/ckj/sfab140.
  3. Nakken S, Eikrem Ø, Marti HP, Beisland C, Bostad L, Scherer A, Flatberg A, Beisvag V, Skandalou E, Furriol J, Strauss P. Cancer Cell Int. 2021 Dec 20;21(1):690. doi: 10.1186/s12935-021-02395-9.
  4. Strauss P, Mikkelsen H, Furriol J. PLoS One. 2021 Dec 9;16(12):e0259373. doi: 10.1371/journal.pone.0259373.
  5. Chen TJ, Mydel P, Benedyk-Machaczka M, Kamińska M, Kalucka U, Blø M, Furriol J, Gausdal G, Lorens J, Osman T, Marti HP. . Physiol Rep. 2021 Dec;9(23):e15140. doi: 10.14814/phy2.15140.
  6. Eikrem O, Kotopoulis S, Popa M, Mayoral Safont M, Fossan KO, Leh S, Landolt L, Babickova J, Gudbrandsen OA, Gilja OH, Riedel B, Schjøtt J, McCormack E, Marti HP. Pharmaceutics. 2021 Nov 29;13(12):2038. doi: 10.3390/pharmaceutics13122038.
  7. Fraggetta F, L'Imperio V, Ameisen D, Carvalho R, Leh S, Kiehl TR, Serbanescu M, Racoceanu D, Della Mea V, Polonia A, Zerbe N, Eloy C. Diagnostics (Basel). 2021 Nov 22;11(11):2167. doi: 10.3390/diagnostics11112167.
  8. Hervig T, Tvedt THA, Knoop T, Sandnes M, Reikvam H. Tidsskr Nor Laegeforen. 2021 Nov 8;141(16). doi: 10.4045/tidsskr.21.0171.
  9. Mohamed N, Litlekalsøy J, Ahmed IA, Martinsen EMH, Furriol J, Javier-Lopez R, Elsheikh M, Gaafar NM, Morgado L, Mundra S, Johannessen AC, Osman TA, Nginamau ES, Suleiman A, Costea DE. Front Cell Infect Microbiol. 2021 Oct 12;11:673465. doi: 10.3389/fcimb.2021.673465.
  10. Niederhauser C, Tinguely C, Dreier J, Vollmer T, Marti HP, Nickel B, Klemens JM, Warnecke JM, Gowland P. Transfus Med Hemother. 2021 May 26;48(5):265-271. doi: 10.1159/000515842.
  11. Leh F, Stalund IV, Bjånes TK, Ohldieck C, Svarstad E, Leh S. Hum Pathol. 2021 Oct;116:102-111. doi: 10.1016/j.humpath.2021.07.009.
  12. Hoel F, Hoel A, Pettersen IK, Rekeland IG, Risa K, Alme K, Sørland K, Fosså A, Lien K, Herder I, Thürmer HL, Gotaas ME, Schäfer C, Berge RK, Sommerfelt K, Marti HP, Dahl O, Mella O, Fluge Ø, Tronstad KJ. JCI Insight. 2021 Aug 23;6(16):e149217. doi: 10.1172/jci.insight.149217.
  13. Gjerde A, Skrunes R, Reisæter AV, Marti HP, Vikse BE. Kidney Int Rep. 2021 May 30;6(8):2151-2158. doi: 10.1016/j.ekir.2021.05.032.
  14. Hoel A, Osman T, Hoel F, Elsaid H, Chen T, Landolt L, Babickova J, Tronstad KJ, Lorens JB, Gausdal G, Marti HP, Furriol J. J Cell Mol Med. 2021 Aug;25(15):7407-7417. doi: 10.1111/jcmm.16769.
  15. Midtvedt K, Tran T, Parker K, Marti HP, Stenehjem AE, Gøransson LG, Mørkve Soldal K, Madsen C, Smedbråten J, Vaage EB, Lund-Johansen F, Åsberg A. Transplantation. 2021 Aug 1;105(8):e80-e81. doi: 10.1097/TP.0000000000003856.
  16. Steinfeld PF, Knoop T, Trovik LH, Gjelberg HK, Haslerud TM, Reikvam H. Clin Pract. 2021 Jul 22;11(3):459-466. doi: 10.3390/clinpract11030061.
  17. Dendooven A, Peetermans H, Helbert M, Nguyen TQ, Marcussen N, Nagata M, Gesualdo L, Perkowska-Ptasinska A, Capusa C, López-Gómez JM, Geddes C, Abdul-Hamid MA, Segelmark M, Yahya R, Garau M, Villanueva R, Dorman A, Barbour S, Cornet R, Hopfer H, Amann K, Leh S; Kidney Biopsy Codes for Pathologists project (). BMC Nephrol. 2021 May 24;22(1):193. doi: 10.1186/s12882-021-02365-3.
  18. Kelly DM, Anders HJ, Bello AK, Choukroun G, Coppo R, Dreyer G, Eckardt KU, Johnson DW, Jha V, Harris DCH, Levin A, Lunney M, Luyckx V, Marti HP, Messa P, Mueller TF, Saad S, Stengel B, Vanholder RC, Weinstein T, Khan M, Zaidi D, Osman MA, Ye F, Tonelli M, Okpechi IG, Rondeau E; ISN Western Europe Regional Board Kidney Int Suppl (2011). 2021 May;11(2):e106-e118. doi: 10.1016/j.kisu.2021.01.007.
  19. Rossi F, Svarstad E, Elsaid H, Binaggia A, Roggero L, Auricchio S, Marti HP, Pieruzzi F. High Blood Press Cardiovasc Prev. 2021 May;28(3):309-319. doi: 10.1007/s40292-021-00450-0.
  20. Stalund IV, Riise GN, Leh F, Bjånes TK, Riise L, Svarstad E, Leh S. F1000Res. 2021 Apr 19;10:300. doi: 10.12688/f1000research.51927.2.
  21. Haaskjold YL, Nylund K, Skrunes R. Case Rep Nephrol Dial. 2021 Feb 12;11(1):63-68. doi: 10.1159/000512228.
  22. Rossi F, L'Imperio V, Marti HP, Svarstad E, Smith A, Bolognesi MM, Magni F, Pagni F, Pieruzzi F. . Mol Genet Metab. 2021 Feb;132(2):86-93. doi: 10.1016/j.ymgme.2020.10.006.
  23. van der Veen SJ, Körver S, Hirsch A, Hollak CEM, Wijburg FA, Brands MM, Tøndel C, van Kuilenburg ABP, Langeveld M.  Mol Genet Metab. 2022 Feb;135(2):163-169. doi: 10.1016/j.ymgme.2021.12.004. Epub 2021 Dec 17.
  24. Eide TT, Hufthammer KO, Brun A, Brackman D, Svarstad E, Tøndel C.  Sci Rep. 2021 Dec 1;11(1):23224. doi: 10.1038/s41598-021-02759-1.
  25. Casabona G, Habib MA, Povey M, Riise Bergsaker MA, Flodmark CE, Espnes KA, Tøndel C, Silfverdal SA.  Acta Paediatr. 2022 Feb;111(2):391-400. doi: 10.1111/apa.16136. Epub 2021 Oct 28.
  26. Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, Sævik M, Bartsch H, Tøndel C, Kittang BR; Bergen COVID-19 Research Group; Cox RJ, Langeland N.  Nat Med. 2021 Sep;27(9):1607-1613. doi: 10.1038/s41591-021-01433-3. Epub 2021 Jun 23.
  27. Baka-Ostrowska M, Bolong DT, Persu C, Tøndel C, Steup A, Lademacher C, Martin N.  Neurourol Urodyn. 2021 Aug;40(6):1490-1499. doi: 10.1002/nau.24657. Epub 2021 May 31.
  28. Kuwelker K, Zhou F, Blomberg B, Lartey S, Brokstad KA, Trieu MC, Bansal A, Madsen A, Krammer F, Mohn KG, Tøndel C, Linchausen DW, Cox RJ, Langeland N; Bergen COVID-19 research group.  Lancet Reg Health Eur. 2021 Apr;3:100014. doi: 10.1016/j.lanepe.2020.100014. Epub 2021 Mar 31.
  29. Arrieta AC, Ang JY, Espinosa C, Fofanov O, Tøndel C, Chou MZ, De Anda CS, Kim JY, Li D, Sabato P, Sears PS, Bradley JS.  Pediatr Infect Dis J. 2021 Apr 1;40(4):317-323. doi: 10.1097/INF.0000000000003030.
  30. Moreno-Martinez D, Aguiar P, Auray-Blais C, Beck M, Bichet DG, Burlina A, Cole D, Elliott P, Feldt-Rasmussen U, Feriozzi S, Fletcher J, Giugliani R, Jovanovic A, Kampmann C, Langeveld M, Lidove O, Linhart A, Mauer M, Moon JC, Muir A, Nowak A, Oliveira JP, Ortiz A, Pintos-Morell G, Politei J, Rozenfeld P, Schiffmann R, Svarstad E, Talbot AS, Thomas M, Tøndel C, Warnock D, West ML, Hughes DA.  Mol Genet Metab. 2021 Apr;132(4):234-243. doi: 10.1016/j.ymgme.2021.02.001. Epub 2021 Feb 20.
  31. Lillås BS, Tøndel C, Aßmus J, Vikse BE.  Nephrol Dial Transplant. 2021 Dec 31;37(1):92-99. doi: 10.1093/ndt/gfaa306.
  32. Trieu MC, Bansal A, Madsen A, Zhou F, Sævik M, Vahokoski J, Brokstad KA, Krammer F, Tøndel C, Mohn KGI, Blomberg B, Langeland N, Cox RJ; Bergen COVID-19 Research Group. . J Infect Dis. 2021 Feb 24;223(4):589-599. doi: 10.1093/infdis/jiaa737.
  33. Lillås BS, Tøndel C, Gjerde A, Vikse BE.  Clin Kidney J. 2019 Nov 26;14(1):181-188. doi: 10.1093/ckj/sfz167. eCollection 2021 Jan.
2020
  1. Pichler Sekulic S, Marti HP, Sekulic M. Kidney Int. 2020 Nov;98(5):1359-1360. doi: 10.1016/j.kint.2020.06.006.
  2. Liang KX, Kristiansen CK, Mostafavi S, Vatne GH, Zantingh GA, Kianian A, Tzoulis C, Høyland LE, Ziegler M, Perez RM, Furriol J, Zhang Z, Balafkan N, Hong Y, Siller R, Sullivan GJ, Bindoff LA. EMBO Mol Med. 2020 Oct 7;12(10):e12146. doi: 10.15252/emmm.202012146.
  3. Gjerde A, Reisæter AV, Skrunes R, Marti HP, Vikse BE.  Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1413-1423. doi: 10.2215/CJN.04080320.
  4. Apeland T, Mansoor MA, Furriol J, Ushakova A, Jonsson G, Stangeland KW, Marti HP. Free Radic Biol Med. 2020 Aug 1;155:10-18. doi: 10.1016/j.freeradbiomed.2020.05.005.
  5. Gjerde A, Lillås BS, Marti HP, Reisæter AV, Vikse BE. Nephrol Dial Transplant. 2020 Jul 1;35(7):1157-1163. doi: 10.1093/ndt/gfaa001.
  6. Svarstad E, Marti HP. Clin J Am Soc Nephrol. 2020 Apr 7;15(4):569-576. doi: 10.2215/CJN.09480819
  7. Mohn KG, Brokstad KA, Islam S, Oftung F, Tøndel C, Aarstad HJ, Cox RJ.  J Infect Dis. 2020 Apr 7;221(9):1528-1537. doi: 10.1093/infdis/jiz583.
  8. Najafian B, Tøndel C, Svarstad E, Gubler MC, Oliveira JP, Mauer M.  J Am Soc Nephrol. 2020 Apr;31(4):865-875. doi: 10.1681/ASN.2019050497. Epub 2020 Mar 3.
  9. Thorsteinsdottir H, Salvador CL, Mjøen G, Lie A, Sugulle M, Tøndel C, Brun A, Almaas R, Bjerre A.  Dis Markers. 2020 Feb 6;2020:6162892. doi: 10.1155/2020/6162892. eCollection 2020.
  10. Rittig S, Baka-Ostrowska M, Tøndel C, Walle JV, Kjaeer B, Passier P, Bosman B, Stroosma O, Tannenbaum S.  J Pediatr Urol. 2020 Feb;16(1):31.e1-31.e10. doi: 10.1016/j.jpurol.2019.10.009. Epub 2019 Oct 22.
  11. Rossi F, L'Imperio V, Marti HP, Svarstad E, Smith A, Bolognesi MM, Magni F, Pagni F, Pieruzzi F.  Mol Genet Metab. 2021 Feb;132(2):86-93. doi: 10.1016/j.ymgme.2020.10.006. Epub 2020 Oct 14. 
2019
  1. Knoop T, Larsen KK, Leh F, Hemsing AL, Teigen IA, Reikvam H. Clin Pract. 2019 Dec 19;9(4):1184. doi: 10.4081/cp.2019.1184.
  2. Paunas FTI, Finne K, Leh S, Osman TA, Marti HP, Berven F, Vikse BE. BMC Nephrol. 2019 Nov 14;20(1):410. doi: 10.1186/s12882-019-1598-1.
  3. Marti HP, Serebruany V, Atar D.  Am J Med. 2019 Nov;132(11):1258-1259. doi: 10.1016/j.amjmed.2019.07.002.
  4. Hodneland E, Keilegavlen E, Hanson EA, Andersen E, Monssen JA, Rorvik J, Leh S, Marti HP, Lundervold A, Svarstad E, Nordbotten JM. IEEE Trans Biomed Eng. 2019 Jun;66(6):1779-1790. doi: 10.1109/TBME.2018.2879362.
  5. Landolt L, Furriol J, Babickova J, Ahmed L, Eikrem Ø, Skogstrand T, Scherer A, Suliman S, Leh S, Lorens JB, Gausdal G, Marti HP, Osman T. Physiol Rep. 2019 May;7(10):e14091. doi: 10.14814/phy2.14091.
  6. Becirovic-Agic M, Jönsson S, Tveitarås MK, Skogstrand T, Karlsen TV, Lidén Å, Leh S, Ericsson M, Nilsson SK, Reed RK, Hultström M. Am J Physiol Regul Integr Comp Physiol. 2019 May 1;316(5):R563-R570. doi: 10.1152/ajpregu.00373.2018.
  7. Koch E, Finne K, Eikrem Ø, Landolt L, Beisland C, Leh S, Delaleu N, Granly M, Vikse BE, Osman T, Scherer A, Marti HP. Am J Physiol Renal Physiol. 2019 May 1;316(5):F1053-F1067. doi: 10.1152/ajprenal.00424.2018.
  8. Jönsson S, Becirovic-Agic M, Isackson H, Tveitarås MK, Skogstrand T, Narfström F, Karlsen TV, Lidén Å, Leh S, Ericsson M, Nilsson SK, Reed RK, Hultström M. Am J Physiol Renal Physiol. 2019 May 1;316(5):F914-F933. doi: 10.1152/ajprenal.00483.2018.
  9. Rondeau E, Luyckx VA, Anders HJ, Eckardt KU, Florquin S, Marti HP, Ølgaard K, Harden P; members of the Western Europe Regional Board, International Society of Nephrology Kidney Int. 2019 May;95(5):1037-1040. doi: 10.1016/j.kint.2018.09.028.
  10. Nylund K, Sævik F, Leh S, Pfeffer F, Hausken T, Gilja OH. Ultraschall Med. 2019 Feb;40(1):76-84. doi: 10.1055/s-0044-100492.
  11. Hodneland E, Keilegavlen E, Hanson EA, Andersen E, Monssen JA, Rorvik J, Leh S, Marti HP, Lundervold A, Svarstad E, Nordbotten JM. . IEEE Trans Biomed Eng. 2019 Jun;66(6):1779-1790. doi: 10.1109/TBME.2018.2879362.
  12. Nylund K, Sævik F, Leh S, Pfeffer F, Hausken T, Gilja OH.  Ultraschall Med. 2019 Feb;40(1):76-84. doi: 10.1055/s-0044-100492.
  13. Lillås BS, Tøndel C, Gjerde A, Vikse BE.  Clin Kidney J. 2019 Nov 26;14(1):181-188. doi: 10.1093/ckj/sfz167. eCollection 2021 Jan.
  14. Ramaswami U, Bichet DG, Clarke LA, Dostalova G, Fainboim A, Fellgiebel A, Forcelini CM, An Haack K, Hopkin RJ, Mauer M, Najafian B, Scott CR, Shankar SP, Thurberg BL, Tøndel C, Tylki-Szymanska A, Bénichou B, Wijburg FA.  Mol Genet Metab. 2019 May;127(1):86-94. doi: 10.1016/j.ymgme.2019.03.010. Epub 2019 Apr 3.
  15. Salvador CL, Tøndel C, Rowe AD, Bjerre A, Brun A, Brackman D, Mørkrid L.  Pediatr Nephrol. 2019 Feb;34(2):301-311. doi: 10.1007/s00467-018-4067-3. Epub 2018 Aug 31.
  16. Spada M, Baron R, Elliott PM, Falissard B, Hilz MJ, Monserrat L, Tøndel C, Tylki-Szymańska A, Wanner C, Germain DP.  Mol Genet Metab. 2019 Mar;126(3):212-223. doi: 10.1016/j.ymgme.2018.04.007. Epub 2018 Apr 26.
2018
  1. Dierkes J, Dahl H, Welland NL, Sandnes K, Sæle K, Sekse I, Marti HP. BMC Nephrol. 2018 Dec 24;19(1):375. doi: 10.1186/s12882-018-1149-1.
  2. Ruggajo P, Leh S, Svarstad E, Marti HP, Vikse BE BMC Nephrol. 2018 Oct 22;19(1):287. doi: 10.1186/s12882-018-1070-7.
  3. Dierkes J, Dahl H, Lervaag Welland N, Sandnes K, Sæle K, Sekse I, Marti HP. BMC Nephrol. 2018 Oct 11;19(1):259. doi: 10.1186/s12882-018-1055-6.
  4. Eikrem Ø, Walther TC, Flatberg A, Beisvag V, Strauss P, Farstad M, Beisland C, Koch E, Mueller TF, Marti HP. BMC Nephrol. 2018 Sep 5;19(1):221. doi: 10.1186/s12882-018-1012-4.
  5. Tariq A, Mansoor MA, Marti HP, Jonsson G, Slettan A, Weeraman P, Apeland T. Clin Biochem. 2018 Jun;56:33-40. doi: 10.1016/j.clinbiochem.2018.04.010.
  6. Vikøren LA, Drotningsvik A, Mwakimonga A, Leh S, Mellgren G, Gudbrandsen OA. J Am Soc Hypertens. 2018 Apr;12(4):294-302. doi: 10.1016/j.jash.2018.01.006.
  7. Strauss P, Marti HP, Beisland C, Scherer A, Lysne V, Leh S, Flatberg A, Koch E, Beisvag V, Landolt L, Skogstrand T, Eikrem Ø. Int J Mol Sci. 2018 Mar 10;19(3):803. doi: 10.3390/ijms19030803.
  8. Svarstad E, Leh S, Skrunes R, Kampevold Larsen K, Eikrem Ø, Tøndel C. Nephron. 2018;138(1):13-21. doi: 10.1159/000479751.
  9. Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ.  Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12.
  10. Tøndel C, Salvador CL, Hufthammer KO, Bolann B, Brackman D, Bjerre A, Svarstad E, Brun A.  Pediatr Nephrol. 2018 Apr;33(4):683-696. doi: 10.1007/s00467-017-3841-y. Epub 2017 Nov 13.
2017
  1. Nowak A, Koch G, Huynh-Do U, Siegenthaler M, Marti HP, Pfister M. Kidney Blood Press Res. 2017 Feb 28;42(1):1-15. doi: 10.1159/000464312. [Epub ahead of print]
  2. Schiffmann R, Hughes DA, Linthorst GE, Ortiz A, Svarstad E, Warnock DG, West ML, Wanner C; Conference Participants. Kidney Int. 2017 Feb;91(2):284-293. doi: 10.1016/j.kint.2016.10.004
  3. Tøndel C, Bolann B, Salvador CL, Brackman D, Bjerre A, Svarstad E, Brun A. Pediatr Nephrol. 2017 Feb;32(2):311-320. doi: 10.1007/s00467-016-3436-z. Erratum in:
  4. Tøndel C, Bolann B, Salvador CL, Brackman D, Bjerre A, Svarstad E, Brun A. Pediatr Nephrol. 2017 Feb;32(2):375-376. doi: 10.1007/s00467-016-3479-1. No abstract available.
  5. Brackman D, Sartz L, Leh S, Kristoffersson AC, Bjerre A, Tati R, Frémeaux-Bacchi V, Karpman D. Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis. Nephrol Dial Transplant. 2017 Mar 1;32(3):584. doi: 10.1093/ndt/gfx013. No abstract available
  6. Skrunes R, Svarstad E, Kampevold Larsen K, Leh S, Tøndel C. Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients. Nephrol Dial Transplant. 2017 May 1;32(5):807-813
  7. Low Birth Weight and Nephron Number Working Group. Nephron. 2017;136(1):3-49. doi: 10.1159/000457967. Epub 2017 Mar 21
  8. Suntjens E, Dreschler WA, Hess-Erga J, Skrunes R, Wijburg FA, Linthorst GE, Tøndel C, Biegstraaten M. Hearing loss in children with Fabry disease. J Inherit Metab Dis. 2017 May 31. doi: 10.1007/s10545-017-0051-5. [Epub ahead of print]
  9. Landolt L, Eikrem Ø, Strauss P, Scherer A, Lovett DH, Beisland C, Finne K, Osman T, Ibrahim MM, Gausdal G, Ahmed L, Lorens JB, Thiery JP, Tan TZ, Sekulic M, Marti HP. Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis. Physiol Rep. 2017 Jun;5(11). pii: e13305. doi: 10.14814/phy2.13305
  10. Luyckx VA, Perico N, Somaschini M, Manfellotto D, Valensise H, Cetin I, Simeoni U, Allegaert K, Vikse BE, Steegers EA, Adu D, Montini G, Remuzzi G, Brenner BM; writing group of the Low Birth Weight and Nephron Number Working Group. Lancet. 2017 Jul 22;390(10092):424-428.
  11. Norby GE, Mjøen G, Bjørneklett R, Vikse BE, Holdaas H, Svarstad E, Aasarød K. Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry. Lupus. 2017 Jul;26(8):881-885
  12. Midtvedt K, Bergan S, Reisæter AV, Vikse BE, Åsberg A. Transplantation. 2017 Jul;101(7):e214-e217
  13. Eikrem Ø, Skrunes R, Tøndel C, Leh S, Houge G, Svarstad E, Marti HP. Pathomechanisms of renal Fabry disease. Cell Tissue Res. 2017 Jul;369(1):53-62
  14. Skrunes R, Tøndel C, Leh S, Larsen KK, Houge G, Davidsen ES, Hollak C, van Kuilenburg ABP, Vaz FM, Svarstad E  Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease. Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1470-1479
  15. Paunas TIF, Finne K, Leh S, Marti HP, Mollnes TE, Berven F, Vikse BE. Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy. Clin Proteomics. 2017 Aug 14;14:30. doi: 10.1186/s12014-017-9165-x. eCollection 2017
  16. Svarstad E, Leh S, Skrunes R, Kampevold Larsen K, Eikrem Ø, Tøndel C. Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid Deposits. Nephron. 2017 Aug 26. doi: 10.1159/000479751. [Epub ahead of print]
  17. Egeland GM, Skurtveit S, Sakshaug S, Daltveit AK, Vikse BE, Haugen M. Low Calcium Intake in Midpregnancy Is Associated with Hypertension Development within 10 Years after Pregnancy: The Norwegian Mother and Child Cohort Study. J Nutr. 2017 Sep;147(9):1757-1763
  18. Salvador CL, Tøndel C, Rowe AD, Bjerre A, Brun A, Brackman D, Bolstad N, Mørkrid L. Renal Function Influences Diagnostic Markers in Serum and Urine: A Study of Guanidinoacetate, Creatine, Human Epididymis Protein 4, and Neutrophil Gelatinase-Associated Lipocalin in Children. J Appl Lab Med. 2017 Nov 1;2(3):297-308. doi: 10.1373/jalm.2016.022145.  
2016
  1. Finne K, Marti HP, Leh S, Skogstrand T, Vethe H, Tenstad O, Berven FS, Scherer A, Vikse BE. Proteomic Analysis of Minimally Damaged Renal Tubular Tissue from Two-Kidney-One-Clip Hypertensive Rats Demonstrates Extensive Changes Compared to Tissue from Controls. Nephron. 2016;132(1):70-80. doi: 10.1159/000442825. Epub 2016 Jan 9.
  2. Ruggajo P, Skrunes R, Svarstad E, Skjærven R, Reisæther AV, Vikse BE. Familial Factors, Low Birth Weight, and Development of ESRD: A Nationwide Registry Study. Am J Kidney Dis. 2016 Apr;67(4):601-8. doi: 10.1053/j.ajkd.2015.11.015. Epub 2015 Dec 31.
  3. Eikrem O, Beisland C, Hjelle K, Flatberg A, Scherer A, Landolt L, Skogstrand T, Leh S, Beisvag V, Marti HP. Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development.PLoS One. 2016 Feb 22;11(2):e0149743. doi: 10.1371/journal.pone.0149743. eCollection 2016.
  4. Kristoffersen AH, Bjånes TK, Jordal S, Leh S, Leh F, Svarstad E. Polyvinylpyrrolidone induced artefactual prolongation of activated partial thromboplastin times in intravenous drug users with renal failure. J Thromb Haemost. 2016 Feb 26. doi: 10.1111/jth.13299.
  5. Havre RF, Leh SM, Gilja OH, Ødegaard S, Waage JE, Baatrup G, Nesje LB. Differentiation of Metastatic and Non-Metastatic Mesenteric Lymph Nodes by Strain Elastography in Surgical Specimens. Ultraschall Med. 2016 Apr 12.
  6. Najafian B, Tøndel C, Svarstad E, Sokolovkiy A, Smith K, Mauer M. One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease. PLoS One. 2016 Apr 15;11(4):e0152812. doi: 10.1371/journal.pone.0152812. eCollection 2016.
  7. Ruggajo P, Svarstad E, Leh S, Marti HP, Reisæther AV, Vikse BE. Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy-A Retrospective Registry-Based Cohort Study. PLoS One. 2016 Apr 19;11(4):e0153819. doi: 10.1371/journal.pone.0153819. eCollection 2016.
  8. Mohn KG, Brokstad KA, Pathirana RD, Bredholt G, Jul-Larsen Å, Trieu MC, Lartey SL, Montomoli E, Tøndel C, Aarstad HJ, Cox RJ. 
    Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils. J Infect Dis. 2016 Sep 1;214(5):722-31. doi: 10.1093/infdis/jiw230. Epub 2016 May 30. 
2015
  1. Tøndel C, Kanai T, Larsen KK, Ito S, Politei JM, Warnock DG, Svarstad E. . AbstractNephron 2015;129:16-21 (DOI:10.1159/000369309)
  2. Vethe H, Finne K, Skogstrand T, Vaudel M, Vikse BE, Hultström M, Placier S, Scherer A, Tenstad O, Marti HP. J Hypertens. 2015 Jan;33(1):126-35
  3. van der Tol L, Svarstad E, Ortiz A, Tøndel C, Oliveira JP, Vogt L, Waldek S, Hughes DA, Lachmann RH, Terryn W, Hollak CE, Florquin S, van den Bergh Weerman MA, Wanner C, West ML, Biegstraaten M, Linthorst GE. Mol Genet Metab. 2015 Feb;114(2):242-7. doi: 10.1016/j.ymgme.2014.08.007. Epub 2014 Aug 20
  4. Skogstrand T, Leh S, McClure J, Dashti M, Iversen BM, Graham D, McBride MW, Hultström M. J Hypertens. 2015 Mar;33(3):584-96
  5. Sriskandarajah S, Aasarød K, Skrede S, Knoop T, Reisæter AV, Bjørneklett R. Nephrol Dial Transplant. 2015 30: i67-i75 [Epub ahead of print]
  6. , , , , , , . Use of 3D DCE-MRI for the Estimation of Renal Perfusion and Glomerular Filtration Rate: An Intrasubject Comparison of FLASH and KWIC With a Comprehensive Framework for Evaluation. 2015 Mar;204(3):W273-81. doi: 10.2214/AJR.14.13226
  7. Marti HP, Dörje C, Strøm EH. Ther Umsch. 2015 Mar;72(3):199-206. doi: 10.1024/0040-5930/a000665. German
  8. Biegstraaten M, Arngrímsson R, Barbey F, Boks L, Cecchi F, Deegan PB, Feldt-Rasmussen U, Geberhiwot T, Germain DP, Hendriksz C, Hughes DA, Kantola I, Karabul N, Lavery C, Linthorst GE, Mehta A, van de Mheen E, Oliveira JP, Parini R, Ramaswami U, Rudnicki M, Serra A, Sommer C, Sunder-Plassmann G, Svarstad E, Sweeb A, Terryn W, Tylki-Szymanska A, Tøndel C, Vujkovac B, Weidemann F, Wijburg FA, Woolfson P, Hollak CE. Orphanet J Rare Dis. 2015 Mar 27;10:36. doi: 10.1186/s13023-015-0253-6
  9. Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R. Am J Nephrol. 2015;41(3):210-9. doi: 10.1159/000381403. Epub 2015 Apr 9
  10. Wijburg FA, Bénichou B, Bichet DG, Clarke LA, Dostalova G, Fainboim A, Fellgiebel A, Forcelini C, An Haack K, Hopkin RJ, Mauer M, Najafian B, Scott CR, Shankar SP, Thurberg BL, Tøndel C, Tylki-Szymańska A, Ramaswami U. PLoS One. 2015 May 8;10(5):e0124987. doi: 10.1371/journal.pone.0124987. eCollection 2015
  11. Mohn KG, Bredholt G, Brokstad KA, Pathirana RD, Aarstad HJ, Tøndel C, Cox RJ. J Infect Dis. 2015 May 15;211(10):1541-9
  12. Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch H, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study. Clin Infect Dis. 2015 Aug 15;61(4):619-22
  13. Pesce F, Diciolla M, Binetti G, Naso D, Ostuni VC, Di Noia T, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Di Sciascio E, Schena FP. Nephrol Dial Transplant. 2015 Jun 4. pii: gfv232. [Epub ahead of print]
  14. Haaskjold YL, Drotningsvik A, Leh S, Marti HP, Svarstad E. Am J Med. 2015 Jul 30. pii: S0002-9343(15)00682-8. doi: 10.1016/j.amjmed.2015.07.010. [Epub ahead of print] No abstract available
  15. Øvrehus MA, Zürbig P, Vikse BE, Hallan SI. Clin Proteomics. 2015 Aug 7;12(1):21. doi: 10.1186/s12014-015-9092-7. eCollection 2015
  16. den Hoedt CH, Grooteman MP, Bots ML, Blankestijn PJ, van der Tweel I, van der Weerd NC, Penne EL, Mazairac AH, Levesque R, ter Wee PM, Nubé MJ, van den Dorpel MA; CONTRAST investigators. PLoS One. 2015 Aug 19;10(8):e0135908. doi: 10.1371/journal.pone.0135908. eCollection 2015
  17. Diciolla M, Binetti G, Di Noia T, Pesce F, Schena FP, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Naso D. Comput Biol Med. 2015 Nov 1;66:278-86
  18. Quteineh L, Bochud PY, Golshayan D, Crettol S, Venetz JP, Manuel O, Kutalik Z, Treyer A, Lehmann R, Mueller NJ, Binet I, van Delden C, Steiger J, Mohacsi P, Dufour JF, Soccal PM, Pascual M, Eap CB; and The Swiss Transplant Cohort Study. Pharmacogenomics J. 2015 Dec 8. doi: 10.1038/tpj.2015.82. [Epub ahead of print]
  19. Salvador CL, Tøndel C, Mørkrid L, Bjerre A, Brun A, Bolann B, Brackman D, Bergan S. Scand J Clin Lab Invest. 2015 Dec;75(8):710-6
  20. Fredrick FF, Ruggajo PJ, Basu G, Svarstad E, Langeland N. Kidney Int. 2015 Dec;88(6):1211-1214
  21. Tveitarås MK, Skogstrand T, Leh S, Helle F, Iversen BM, Chatziantoniou C, Reed RK, Hultström M. PLoS One. 2015 Dec 16;10(12):e0143390. doi: 10.1371/journal.pone.0143390. eCollection 2015.
  22. Ruggajo P, Skrunes R, Svarstad E, Skjærven R, Reisæther AV, Vikse BE. Familial Factors, . Am J Kidney Dis. 2015 Dec 31. pii: S0272-6386(15)01434-1.doi:10.1053/j.ajkd.2015.11.015. [Epub ahead of print]
2014
  1. den Hoedt CH, Bots ML, Grooteman MP, van der Weerd NC, Penne EL, Mazairac AH, Levesque R, Blankestijn PJ, Nubé MJ, ter Wee PM, van den Dorpel MA; CONTRAST Investigators. Clin J Am Soc Nephrol. 2014 Feb;9(2):318-25. doi: 10.2215/CJN.04470413. Epub 2014 Jan 23
  2. Hirt-Minkowski P, Marti HP, Hönger G, Grandgirard D, Leib SL, Amico P, Schaub S. Transpl Immunol. 2014 Jan;30(1):1-6. doi: 10.1016/j.trim.2013.11.004. Epub 2013 Nov 27
  3. den Hoedt CH, Bots ML, Grooteman MP, van der Weerd NC, Mazairac AH, Penne EL, Levesque R, ter Wee PM, Nubé MJ, Blankestijn PJ, van den Dorpel MA; CONTRAST Investigators. Kidney Int. 2014 Aug;86(2):423-32. doi: 10.1038/ki.2014.9. Epub 2014 Feb 19.
  4. Marti HP, Fuscoe JC, Kwekel JC, Anagnostopoulou A, Scherer A. Nephrol Dial Transplant. 2014 Jun;29(6):1177-85. doi: 10.1093/ndt/gfu027. Epub 2014 Feb 24
  5. Sandvik LF, Skarstein K, Sviland L, Svarstad E, Nilsen AE, Leivestad T, Jonsson R, Appel S. Acta Derm Venereol. 2014 Mar;94(2):173-8. doi: 10.2340/00015555-1679
  6. Aakre KM, Røraas T, Petersen PH, Svarstad E, Sellevoll H, Skadberg O, Sæle K, Sandberg S. Clin Chem. 2014 Jun;60(6):838-47. doi: 10.1373/clinchem.2013.216978. Epub 2014 Mar 11
  7. van der Weerd NC, Den Hoedt CH, Blankestijn PJ, Bots ML, van den Dorpel MA, Lévesque R, Mazairac AH, Nubé MJ, Penne EL, ter Wee PM, Grooteman MP; CONTRAST Investigators. PLoS One. 2014 Apr 17;9(4):e94434. doi: 10.1371/journal.pone.0094434. eCollection 2014
  8. Skrunes R, Svarstad E, Reisæter AV, Vikse BE. Clin J Am Soc Nephrol. 2014 Aug 4. pii: CJN.01680214. [Epub ahead of print]
  9. Finne K, Vethe H, Skogstrand T, Leh S, Dahl TD, Tenstad O, Berven FS, Reed RK, Vikse BE. Nephrol Dial Transplant. 2014 Dec;29(12):2217-27. doi: 10.1093/ndt/gfu268. Epub 2014 Aug 16
  10. van der Tol L, Svarstad E, Ortiz A, Tøndel C, Oliveira JP, Vogt L, Waldek S, Hughes DA, Lachmann RH, Terryn W, Hollak CE, Florquin S, van den Bergh Weerman MA, Wanner C, West ML, Biegstraaten M, Linthorst GE. Mol Genet Metab. 2014 Aug 20. pii: S1096-7192(14)00261-3. doi: 10.1016/j.ymgme.2014.08.007. [Epub ahead of print]
  11. van der Tol L, Cassiman D, Houge G, Janssen MC, Lachmann RH, Linthorst GE, Ramaswami U, Sommer C, Tøndel C, West ML, Weidemann F, Wijburg FA, Svarstad E, Hollak CE, Biegstraaten M. JIMD Rep. 2014 Sep 16. [Epub ahead of print]
  12. Vethe H, Finne K, Skogstrand T, Vaudel M, Vikse BE, Hultström M, Placier S, Scherer A, Tenstad O, Marti HP. J Hypertens. 2014 Oct 9. [Epub ahead of print]
  13. Mauer M, Glynn E, Svarstad E, Tøndel C, Gubler MC, West M, Sokolovskiy A, Whitley C, Najafian B. PLoS One. 2014 Nov 11;9(11):e112188. doi: 10.1371/journal.pone.0112188. eCollection 2014
  14. Skogstrand T, Leh S, McClure J, Dashti M, Iversen BM, Graham D, McBride MW, Hultström M. Identification of a common molecular pathway in hypertensive renal damage: comparison of rat and human gene expression profiles. J Hypertens. 2014 Nov 6. [Epub ahead of print]
  15. Tøndel C, Kanai T, Larsen K.K, Ito S, Politei JM, Warnock DG, Svarstad E. Foot Process Effacement Is an Early Marker of Nephropathy in Young Classic Fabry Patients without Albuminuria. Nephron Online First, E-pub Dec 18. 2013. DOI:10.1159/000369309
2013

1. Tøndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, Svarstad E. J Am Soc Nephrol. 2013 Jan;24(1):137-48. doi: 10.1681/ASN.2012030316

2. Skogstrand T, Leh S, Paliege A, Reed RK, Vikse BE, Bachmann S, Iversen BM Late, Hultström M. Arterial damage precedes the development of interstitial damage in the nonclipped kidney of two-kidney, one-clip hypertensive rats. J Hypertens. 2013 Jan;31(1):152-9. doi: 10.1097/HJH.0b013e32835a5d4e

3. Mazairac AH, de Wit GA, Grooteman MP, Penne EL, van der Weerd NC, den Hoedt CH, Lévesque R, van den Dorpel MA, Nubé MJ, ter Wee PM, Bots ML, Blankestijn PJ; CONTRAST Investigators. Effect of hemodiafiltration on quality of life over time. Clin J Am Soc Nephrol. 2013 Jan;8(1):82-9. doi: 10.2215/CJN.00010112. Epub 2012 Nov 2

4. Helle F, Karlsen TV, Tenstad O, Titze J, Wiig H.  Acta Physiol (Oxf). 2013 Mar;207(3):577-81. doi: 10.1111/apha.12049. Epub 2013 Jan 10

5. Linthorst GE, Burlina AP, Cecchi F, Cox TM, Fletcher JM, Feldt-Rasmussen U, Giugliani R, Hollak CE, Houge G, Hughes D, Kantola I, Lachmann R, Lopez M, Ortiz A, Parini R, Rivera A,Rolfs A, Ramaswami U, Svarstad E, Tondel C, Tylki-Szymanska A, Vujkovac B, Waldek S, West M, Weidemann F, Mehta A. Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage. JIMD Rep. 2013;8:51-6. doi: 10.1007/8904_2012_160. Epub 2012 Jul 14

6. Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A; NILS Study Group.  Clin Transplant. 2013 Mar-Apr;27(2):E151-6. doi: 10.1111/ctr.12076. Epub 2013 Jan 27

7. Bertelsen AK, Tøndel C, Krohn J, Bull N, Aarseth J, Houge G, Mellgren SI, Vedeler CA.  J Neurol. 2013 Mar;260(3):917-9. doi: 10.1007/s00415-012-6800-3. Epub 2012 Dec 21. No abstract available

8. Helle F, Skogstrand T, Schwartz IF, Schwartz D, Iversen BM, Palm F, Hultström M.  Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1088-98. doi: 10.1152/ajprenal.00665.2011. Epub 2013 Feb 13.

9. den Hoedt CH, Bots ML, Grooteman MP, Mazairac AH, Penne EL, van der Weerd NC, Ter Wee PM, Nubé MJ, Levesque R, Blankestijn PJ, van den Dorpel MA; CONTRAST investigators. Should we still focus that much on cardiovascular mortality in end stage renal disease patients? The CONvective TRAnsport STudy. PLoS One. 2013 Apr 19;8(4):e61155. doi: 10.1371/journal.pone.0061155. Print 2013

10.  Villa L, Boor P, Konieczny A, Kunter U, van Roeyen CR, Denecke B, Gan L, Neusser MA, Cohen CD; ERCB Consortium;, Eitner F, Scholl T, Ostendorf T, Floege J.  J Pathol. 2013 Apr;229(5):672-84. doi: 10.1002/path.4151. Epub 2013 Mar 5

11.  Koller MT, van Delden C, Müller NJ, Baumann P, Lovis C, Marti HP, Fehr T, Binet I, De Geest S, Bucher HC, Meylan P, Pascual M, Steiger J.  Eur J Epidemiol. 2013 Apr;28(4):347-55. doi: 10.1007/s10654-012-9754-y. Epub 2013 Apr 2

12.  Najafian B, Mauer M, Hopkin RJ, Svarstad E.  Pediatr Nephrol. 2013 May;28(5):679-87. doi: 10.1007/s00467-012-2222-9. Epub 2012 Aug 17.

13.  Vikse BE.  Lancet. 2013 Jul 13;382(9887):104-6. doi: 10.1016/S0140-6736(13)60741-2. Epub 2013 May 31

14.  Sandvik MK, Hallan S, Svarstad E, Vikse BE.  Clin J Am Soc Nephrol. 2013 Jul;8(7):1126-34. doi: 10.2215/CJN.10641012. Epub 2013 May 30.

15.  Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE. Lancet. 2013 Jul 20;382(9888):273-83. doi: 10.1016/S0140-6736(13)60311-6. Epub 2013 May 31. Review.

16.  Mazairac AH, Blankestijn PJ, Grooteman MP, Penne EL, van der Weerd NC, den Hoedt CH, Buskens E, van den Dorpel MA, ter Wee PM, Nubé MJ, Bots ML, de Wit GA; CONTRAST investigators.  Nephrol Dial Transplant. 2013 Jul;28(7):1865-73. doi: 10.1093/ndt/gft045. Epub 2013 Jun 13

17.  Sandvik LF, Skarstein K, Sviland L, Svarstad E, Nilsen AE, Leivestad T, Jonsson R, Appel S.  Acta Derm Venereol. 2013 Aug 27. doi: 10.2340/00015555-1679. [Epub ahead of print]

18.  Schartum-Hansen H, Ueland PM, Pedersen ER, Meyer K, Ebbing M, Bleie Ø, Svingen GF, Seifert R, Vikse BE, Nygård O.  PLoS One. 2013 Aug 6;8(8):e69454. doi: 10.1371/journal.pone.0069454. Print 2013

19.  Knoop T, Vikse BE, Svarstad E, Leh S, Reisæter AV, Bjørneklett R.  Am J Kidney Dis. 2013 Nov;62(5):883-90. doi: 10.1053/j.ajkd.2013.04.019. Epub 2013 Jun 21

20.  Hirt-Minkowski P, Marti HP, Hönger G, Grandgirard D, Leib SL, Amico P, Schaub S.  Transpl Immunol. 2013 Nov 27. pii: S0966-3274(13)00100-7. doi: 10.1016/j.trim.2013.11.004. [Epub ahead of print]

21.  Aakre KM, Røraas T, Petersen PH, Svarstad E, Sæle K, Sandberg S.  Clin Chem. 2013 Dec;59(12):1813-4. doi: 10.1373/clinchem.2013.209353. Epub 2013 Sep 16

22.  Sandvik MK, Leirgul E, Nygård O, Ueland PM, Berg A, Svarstad E, Vikse BE. Am J Obstet Gynecol. 2013 Dec;209(6):569.e1-569.e10. doi: 10.1016/j.ajog.2013.07.024. Epub 2013 Jul 27

23. Tøndel C. : PhD-thesis, University of Bergen 2013 (ISBN 978-82-308-2256-2), ϳԹԴ

24. Sandvik MK. Renal disease and cardiovascular risk factors after preeclampsia: PhD-thesis, University of Bergen 2013 (ISBN 978-82-308-2297-5), ϳԹԴ

25. Skogstrand T. Renal hypertensive fibrosis in the rat: PhD-thesis, University of Bergen 2013 (ISBN 978-82-308-2226-5), ϳԹԴ

2012

Warnock DG, Ortiz A, Mauer M, Linthorst GE, Oliveira JP, Serra AL, Maródi L, Mignani R, Vujkovac B, Beitner-Johnson D, Lemay R, Cole JA, Svarstad E, Waldek S, Germain DP, Wanner C; Fabry Registry.  Nephrol Dial Transplant. 2012 Mar;27(3):1042-9. Epub 2011 Jul 29

Hultström M, Leh S, Paliege A, Bachmann S, Skogstrand T, Iversen BM. Collagen-binding proteins in age-dependent changes in renal collagen turnover: microarray analysis of mRNA expression. Physiol Genomics. 2012 May 1;44(10):576-86. Epub 2012 Mar 27

Olstad HD, Svarstad E. [A women in her 50s with leg pain and renal failure]. Tidsskr Nor Laegeforen. 2012 Apr 30;132(8):960-1. Norwegian. No abstract available

Bjørneklett R, Vikse BE, Bostad L, Leivestad T, Iversen BM. Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort. Nephrol Dial Transplant. 2012 Apr;27(4):1485-91. Epub 2011 Aug 5

Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, ter Wee PM, Blankestijn PJ; CONTRAST Investigators. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012 Jun;23(6):1087-96. Epub 2012 Apr 26

Tøndel C, Vikse BE, Bostad L, Svarstad E.  Clin J Am Soc Nephrol. 2012; 7: 1591-7

Rui PO, Svarstad E, Bostad L, Vikse BE. [A man in his fifties with fever, cough and anuria]. Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1621-4. Norwegian. No abstract available

Najafian B, Mauer M, Hopkin RJ, Svarstad E.  Pediatr Nephrol. 2012 Aug 17. [Epub ahead of print]

Vikse BE, Irgens LM, Karumanchi SA, Thadhani R, Varberg Reisæter A, Skjærven R. Familial Factors in the Association between Pre-Eclampsia and Later ESRD. Clin J Am Soc Nephrol. 2012 Nov;7(11):1819-1826. Epub 2012 Sep 6

Skogstrand T, Leh S, Paliege A, Reed RK, Vikse BE, Bachmann S, Iversen BM Late, Hultström M. Arterial damage precedes the development of interstitial damage in the nonclipped kidney of two-kidney, one-clip hypertensive rats. J Hypertens. 2013 Jan;31(1):152-159. [2012 Oct 17. Epub ahead of print]

Zöllner FG, Svarstad E, Munthe-Kaas AZ, Schad LR, Lundervold A, Rørvik J. Assessment of Kidney Volumes From MRI: Acquisition and Segmentation Techniques. AJR Am J Roentgenol. 2012 Nov;199(5):1060-9. doi: 10.2214/AJR.12.8657

Skjaerven R, Wilcox AJ, Klungsøyr K, Irgens LM, Vikse BE, Vatten LJ, Lie RT. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ. 2012 Nov 27;345:e7677. doi: 10.1136/bmj.e7677

Tøndel C, Bostad L, Kampevold Larsen K, Hirth A, Vikse BE, Houge G, Svarstad E. Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease. JASN December 28, 2012 24: 137-148; doi:10.1681/ASN.2012030316

Bjørneklett RO. : PhD-thesis, University of Bergen 2012 (ISBN 978-82-308-1972-2), HAUKELAND ϳԹԴ

Leh S. : PhD-thesis, University of Bergen 2012 (ISBN 978-82-308-1953-1), HAUKELAND ϳԹԴ

2011

Verbeke F, Van Biesen W, Honkanen E, Wikström B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, Rensma PL; CORD Study Investigators. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 2011; 6: 153-159


Najafian B, Svarstad E, Bostad L, Gubler M-C, Tøndel C, Whitley C, Mauer M.Podocyte Injury and GL-3 accumulation are progressive in young patients with Fabry disease. Kidney Int 2011; 79: 663-670. [Advance online publication, December 15, 2010; doi:10.1038/ki.2010.484]


Dahl TD, Hultström M, Iversen BM, Helle F. Adenosine sensitization after angiotensin II stimulation in afferent arterioles from normal rats does not occur during two-kidney, one-clip hypertension. Acta Physiol (Oxf). 2011 Feb;201(2):289-94. doi: 10.1111/j.1748-1716.2010.02177.x


Penne EL, van der Weerd NC, Grooteman MP, Mazairac AH, van den Dorpel MA, Nubé MJ, Bots ML, Lévesque R, ter Wee PM, Blankestijn PJ; CONTRAST investigators. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011Feb;6(2):281-9. [Epub 2010 Oct 28] 


Aakre KM, Thue G, Svarstad E, Skadberg Ø, Sandberg S. Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. Clin Chim Acta.2011 Mar 8. [Epub ahead of print]


Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM. Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients. Clin Transplant. 2011 May;25(3):E356-65. doi: 10.1111/j.1399-0012.2011.01424.x. [Epub 2011 Mar 9]


Boulos N, Helle F, Dussaule JC, Placier S, Milliez P, Djudjaj S, Guerrot D, Joutel A, Ronco P, Boffa JJ, Chatziantoniou C. Notch3 Is Essential for Regulation of the Renal Vascular Tone. Hypertension. 2011 Apr 25. [Epub ahead of print]
 

Houge G, Kaarbø Ø, Bostad L, Tøndel C, Hirth A, Svarstad E.  Fabry or not Fabry – a question of ascertainment. Eur J Hum Genet 2011 May 18. [Epub ahead of print]


Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM. Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients. Clin Transplant. 2011 May;25(3):E356-65. doi: 10.1111/j.1399-0012.2011.01424.x. Epub 2011 Mar 9


Christiansen RE, Fiskerstrand T, Leh S, Haukanes BI, Singh AK, Fervenza FC, Svarstad E. A mother and daughter with unexplained renal failure. Nephron Clin Pract 2011;119:c1–c9 [Published online: May 27, 2011, DOI: 10.1159/000327428]


Leh S, Hultström M, Rosenberger C, Iversen BM. Afferent arteriolopathy and glomerular collapse but not segmental sclerosis induce tubular atrophy in old spontaneously hypertensive rats. Virchows Arch. 2011 Jul;459(1):99-108. Epub 2011 Jun 10


Warnock DW, Ortiz A, Mauer M, Linthorst GE, Oliveira JP, Serra AL, Maródi L, Mignani R, Vujkovac B, Beitner-Johnson D, Lemay R, J. Cole A, Svarstad E, Waldek S, Germain DP,  and Wanner C, on behalf of the Fabry Registry. Renal Outcomes of Agalsidase Beta Treatment for Fabry Disease: Role of Proteinuria and Timing of Treatment Initiation. Nephrol Dial Transplant (2011) 0: 1–8. doi: 10.1093/ndt/gfr420 [Advance Access published July 29, 2011]


Bjørneklett R, Vikse BE, Bostad L, Leivestad T, Iversen BM. Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort.Nephrol Dial Transplant. 2011 Aug 5. [Epub ahead of print]
 

Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ; ASCERTAIN Investigators. Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. Transplantation. 2011 Aug 27;92(4):410-8. Erratum in: Transplantation. 2011 Nov 27;92(10):e61. multiple investigator names added.

2008

Bivol, Liliana-Monica; Berge, Rolf Kristian; Iversen, Bjarne Magnus.

Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 2008 ;Volum 294.(2) s. R438-R447
ϳԹԴ

Bivol, Liliana-Monica; Hultström, Michael; Gudbrandsen, Oddrun Anita; Berge, Rolf Kristian; Iversen, Bjarne Magnus. 
Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 2008 ;Volum 295.(6) s. R1866-R1873
ϳԹԴ

Christiansen, Rolf E.F.; Kolmannskog, Odd; Leh, Sabine; Iversen, Bjarne Magnus; Tenstad, Olav. 
Glomerular charge barrier and development of proteinuria in passive Heymann nephritis. Kidney and Blood Pressure Research 2008 ;Volum 31.(3) s. 203-209
ϳԹԴ

Hultström, Michael; Leh, Sabine; Skogstrand, Trude; Iversen, Bjarne Magnus. 
Upregulation of tissue inhibitor of metalloproteases-1 (TIMP-1) and procollagen-N-peptidase in hypertension-induced renal damage. Nephrology, Dialysis and Transplantation 2008 ;Volum 23.(3) s. 896-903
ϳԹԴ

Svendsen, Elisabeth Berge; Christiansen, Rolf E.F.; Svarstad, Einar; Aase, Steinar Torbjørn.

En kvinne med kronisk nyresvikt, progredierende hudforkalkninger og sepsis.Tidsskrift for Den norske lægeforening 2008 ;Volum 128. ϳԹԴ

Tøndel, Camilla; Bostad, Leif; Hirth, Asle; Svarstad, Einar. 
Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. American Journal of Kidney Diseases 2008 ;Volum 51.(5) s. 767-776
ϳԹԴ

Tøndel, Camilla; Bostad, Leif; Lægreid, Liv Marie; Houge, Gunnar; Svarstad, Einar.

Prominence of glomerular and vascular changes in renal biopsies in children and adolescents with Fabry disease and microalbuminuria. Clinical Therapeutics 2008 ;Volum 30. Suppl. 2 s. S42-S42

ϳԹԴ

Vikse, Bjørn Egil; Irgens, Lorentz; Leivestad, Torbjørn; Hallan, Stein; Iversen, Bjarne Magnus. 
Low birth weight increases risk for end-stage renal disease. Journal of the American Society of Nephrology 2008 ;Volum 19.(1) s. 151-157
ϳԹԴ

Vikse, Bjørn Egil; Irgens, Lorentz M.; Leivestad, Torbjørn; Skjaerven, Rolv; Iversen, Bjarne Magnus. 
Preeclampsia and the risk of end-stage renal disease. New England Journal of Medicine 2008 ;Volum 359.(8) s. 800-809
ϳԹԴ

2007

Bivol, Liliana-Monica; Berge, Rolf Kristian; Iversen, Bjarne Magnus. 
Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension. American Journal of Physiology - Renal Physiology 2007 ;Volum F293.(3) s. F839-845
ϳԹԴ

Bjørneklett, Rune Oskar; Vikse, Bjørn Egil; Svarstad, Einar; Aasarød, Knut; Bostad, Leif; Langmark, Frøydis; Iversen, Bjarne Magnus. 
Long-term risk of cancer in membranous nephropathy patients. American Journal of Kidney Diseases 2007 ;Volum 50. s. 396-403
ϳԹԴ

Hultström, Michael; Skogstrand, Trude; Helle, Frank; Iversen, Bjarne Magnus. 
The mRNA expression of eNOS, iNOS and L-arginine transporters in the afferent arterioles (AA) of 2K1C hypertensive rats. The FASEB Journal 2007 ;Volum 21.(6) s. A899-A899
ϳԹԴ

Skogstrand, Trude; Hultström, Michael; Leh, Sabine; Iversen, Bjarne Magnus. 
Protein expression of factors involved in the development of renal interstitial fibrosis in old SHR. The FASEB Journal 2007 ;Volum 21.(6) s. A899-A899
ϳԹԴ

Stormark, Tor Andre; Strømmen, Kenneth; Iversen, Bjarne Magnus; Matre, Knut.
Three-dimensional ultrasonography can detect the modulation of kidney volume in two-kidney, one-clip hypertensive rats. Ultrasound in Medicine and Biology 2007 ;Volum 33.(12) s. 1882-1888
ϳԹԴ

Vågnes, Kari Stave; Vågnes, Øyvind Brune; Bakken, Vidar. 
Sera from mice immunized with DNA encoding Porphyromonas gingivalis catalytic or adhesin part of HRgpA inhibit degradation of human fibronectin by HRgpA. Oral Microbiology and Immunology 2007 ;Volum 22.(1) s. 46-51
ϳԹԴ

Vågnes, Øyvind Brune; Iversen, Bjarne Magnus; Arendshorst, William J.. 
Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA(2)/isoprostane production. American Journal of Physiology - Renal Physiology 2007 ;Volum 293.(3) s. F860-F867
ϳԹԴ

2006

Helle, Frank; Vågnes, Øyvind Brune; Iversen, Bjarne Magnus. 
Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension. American Journal of Physiology - Renal Physiology 2006 ;Volum 291.(1) s. F140-F147
ϳԹԴ

Vikse, Bjørn Egil; Irgens, Lorentz; Bostad, Leif; Iversen, Bjarne Magnus. 
Adverse perinatal outcome and later kidney biopsy in the mother. Journal of the American Society of Nephrology 2006 ;Volum 17.(3) s. 837-845
ϳԹԴ

2005

Svarstad, Einar; Bostad, Leif; Kaarbøe, Øyvind; Houge, Gunnar; Tøndel, Camilla; Lyngdal, Per Tore; Iversen, Bjarne Magnus. 
Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease. Clinical Nephrology 2005 ;Volum 63.(5) s. 394-401
ϳԹԴ 

 

Bivol, Liliana-Monica; Vågnes, Øyvind Brune; Iversen, Bjarne Magnus. 
The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension. American Journal of Physiology - Renal Physiology 2005 ;Volum 289. s. F393-F400
ϳԹԴ

Hansen, Frank Helle; Vågnes, Øyvind Brune; Iversen, Bjarne Magnus. 
Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat. American Journal of Physiology - Renal Physiology 2005 ;Volum 288. s. F1023-F1031
ϳԹԴ

Svarstad, Einar; Bostad, Leif; Kaarbøe, Øyvind; Houge, Gunnar; Tøndel, Camilla; Lyngdal, Per Tore; Iversen, Bjarne Magnus. 
Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease. Clinical Nephrology 2005 ;Volum 63.(5) s. 394-401
ϳԹԴ

Svarstad, Einar; Urheim, Lasse; Iversen, Bjarne Magnus. 
Critical renal artery stenoses may cause a spectrum of cardiorenal failure and associated thromboembolic events. Clinical Nephrology 2005 ;Volum 63.(6) s. 487-492
ϳԹԴ

Vågnes, Øyvind Brune; Hansen, Frank Helle; Feng, JJ; Iversen, Bjarne Magnus; Arendshorst, WJ. 
Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states. American Journal of Physiology - Renal Physiology 2005 ;Volum 288. s. F1249-F1256
ϳԹԴ

2004

Christiansen, Rolf E.; Tenstad, Olav; Leh, Sabine; Iversen, Bjarne Magnus. 
Glomerular charge selectivity is impaired in hypertensive nephropathy. Nephrology, Dialysis and Transplantation 2004 ;Volum 19. s. 1083-1091
ϳԹԴ

Hansen, Frank; Vågnes, Øyvind Brune; Iversen, Bjarne Magnus; Forslund, Terje.
Enhanced response to arginine vasopressin (AVP) in the interlobular artery (ILA) from the spontaneously hypertensive rat (SHR). American Journal of Physiology - Renal Physiology 2004 
ϳԹԴ

Leh, Sabine; Vågnes, Øyvind Brune; Margolin, Solomon B.; Iversen, Bjarne Magnus; Forslund, Terje. 
Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats. Nephrology, Dialysis and Transplantation 2004 
ϳԹԴ

Strømmen, Kenneth; Stormark, Tor A.; Iversen, Bjarne Magnus; Matre, Knut. 
Volume estimation of small phantoms and rat kidneys using three-dimensional ultrasonography and a position sensor. Ultrasound in Medicine and Biology 2004 ;Volum 30.(9) s. 1109-1117
ϳԹԴ

Svarstad, Einar; Iversen, Bjarne Magnus. 
Renal artery thrombosis and acute renal failure after ACE inhibition. Nephrology, Dialysis and Transplantation 2004 s. 565-
ϳԹԴ

Svarstad, Einar; Iversen, Bjarne Magnus; Bostad, Leif. 
Bedside stereomicroscopy of renal biopsies may lead to a rapid diagnosis of Fabry's disease. Nephrology, Dialysis and Transplantation 2004 ;Volum 19. s. 3202-3203
ϳԹԴ

Vågnes, Kari Stave; Vågnes, Øyvind Brune; Vasstrand, Endre N.; Bakken, Vidar. 
Expression of the beta-adhesin part of HRgpA in Sprague Dawley rats induces a specific antibody response. Oral Microbiology and Immunology 2004 ;Volum 19.(2) s. 77-82
ϳԹԴ

Vågnes, Øyvind Brune; Hansen, Frank; Christiansen, Rolf E.; Gjerstad, C.; Iversen, Bjarne Magnus. 
Age regulation of the V1a receptor in rats with genetic hypertension. American Journal of Physiology - Renal Physiology 2004 ;Volum 286. s. F997-F1003
ϳԹԴ

2003

Midtvedt, Karsten; Fauchald, Per; Bergan, Stein; Høieggen, Aud; Hallan, Stein; Svarstad, Einar; Bergrem, Harald; Eriksen, Bjørn; Pfeffer, Per; Dalen, Ingvild; Leivestad, Torbjørn. 
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?.Transplantation 2003 ;Volum 76.(8) s. 1236-1238
ϳԹԴ

 

Vikse, Bjørn E; Aasarød, Knut Ivar; Bostad, L.; Iversen, B.M.. 
Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrology, Dialysis and Transplantation 2003 ;Volum 18. s. 517-523
ϳԹԴ

Vikse, Bjørn Egil; Aasarød, Knut; Bostad, Leif; Iversen, Bjarne Magnus. 
Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrology, Dialysis and Transplantation 2003 ;Volum 18. s. 517-523
ϳԹԴ

Vågnes, Øyvind B.; Hansen, Frank Helle; Christiansen, Rolf E.F.; Gjerstad, Camilla; Iversen, Bjarne Magnus. 
Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat. American Journal of Physiology - Renal Physiology 2003 
ϳԹԴ

2002

Aaserød, Knut; Iversen, Bjarne Magnus; Hammerstrøm, Jan; Bostad, Leif; Jørstad, Størker. 
Clinical outcome in patients with Wegners granulomatosis treated with plasmapheresis. Blood Purification 2002 ;Volum 20.(2) s. 167-173
ϳԹԴ

Christiansen, Rolf E.F.; Roald, Anca Beatrice; Tenstad, Olav; Iversen, Bjarne Magnus. 
Renal hemodynamics during development of hypertension in young spontaneously hypertensive rats. Kidney and Blood Pressure Research 2002 ;Volum 25. s. 322-328
ϳԹԴ

Svarstad, Einar; Hultstrøm, Dieter; Jensen, Dag; Jenssen, Geir. 
Renal artery thrombosis with acute renal failure after withdrawal of angiotensin converting enzyme inhibitor: a case report. Nephrology, Dialysis and Transplantation2002 ;Volum 17.(4) s. 687-689
ϳԹԴ

Svarstad, Einar; Myking, Ole Langeland; Ofstad, Jarle; Iversen, Bjarne Magnus. 
Effect of light excercise on renal hemodynamics in patients with hypertension and chronic renal disease. Scandinavian Journal of Urology and Nephrology 2002 ;Volum 36.(6) s. 464-473
ϳԹԴ

Surgery 2002 ;Volum 12.(3) s. 312-318
ϳԹԴ

 

Svarstad, Einar; Hultstrøm, Dieter; Jensen, Dag; Jenssen, Geir. 
Renal artery thrombosis with acute renal failure after withdrawal of angiotensin converting enzyme inhibitor: a case report. Nephrology, Dialysis and Transplantation2002 ;Volum 17.(4) s. 687-689
ϳԹԴ

 Vabø, Anne-Lisbeth; Leh, Sabine; Forslund, Terje. 
Interstitial nephritis, acute renal failure in a patient with non-fulminant hepatitis A infection. Clinical Nephrology 2002 ;Volum 57.(2) s. 149-153
ϳԹԴ

 

Vikse, Bjørn E; Bostad, Leif; Aasarød, Knut Ivar; Lysebo, Dag Einar; Iversen, Bjarne M.. 
Prognostic factors in mesangioproliferative glomerulonephritis. Nephrology, Dialysis and Transplantation 2002 ;Volum 17. s. 1603-1613
ϳԹԴ

Vikse, Bjørn Egil; Bostad, Leif; Aasarød, Knut; Lysebo, Dag Einar; Iversen, Bjarne Magnus. 
Prognostic factors in mesangioproliferative glomerulonephritis. Nephrology, Dialysis and Transplantation 2002 ;Volum 17. s. 1603-1613
ϳԹԴ

2001

Aasarød, Knut; Bostad, Leif; Hammerstrøm, Jan; Jørstad, Størker; Iversen, Bjarne Magnus. 
Renal histopathology and clinical course in 94 patients with Wegners granulomatosis. Nephrology, Dialysis and Transplantation 2001 ;Volum 16.(5) s. 953-960
ϳԹԴ

Aasarød, Knut; Bostad, Leif; Hammerstrøm, Jan; Jørstad, Størker; Iversen, Bjarne Magnus. 
Wegners ganulomatosis: Inflammatory cells and markers of repair and fibrosis in renal biopsies. A clinicopathological study. Scandinavian Journal of Urology and Nephrology 2001 ;Volum 35.(5) s. 401-410
ϳԹԴ

Dale, Astrid; Iversen, Bjarne Magnus. 
Ambulatory blood pressure in patients with mesangioproliferative glomerulonephritis. Blood Pressure 2001 ;Volum 10. s. 150-155
ϳԹԴ

Ellingsen, Ivar; Florvaag, Erik; Andreassen, Anders; Iversen, Bjarne Magnus; Irgens, Ågot; Matre, Roald. 
Plasmapheresis in the treatment of steroid-dependent bronchial asthma. Allergy. European Journal of Allergy and Clinical Immunology 2001 ;Volum 56. s. 1202-1205
ϳԹԴ

Gøransson, Lasse G.; Bergrem, Harald. 
Consequences of late referral of patients with end-stage renal disease. Journal of Internal Medicine 2001 ;Volum 250.(2) s. 154-159
ϳԹԴ

Leiva, Rafael Alexander; Svarstad, Einar; Iversen, Bjarne Magnus. 
Akutt dialysebehandling ved Haukeland Sykehus i 1999. Tidsskrift for Den norske lægeforening 2001 ;Volum 121.(15) s. 1774-1779
ϳԹԴ

Svarstad, Einar; Gerdts, Eva; Omvik, Per; Ofstad, Jarle; Iversen, Bjarne Magnus. 
Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus. Kidney and Blood Pressure Research 2001 ;Volum 24. s. 64-70
ϳԹԴ

Svarstad, Einar; Hultstrøm, Dieter; Jensen, Dag; Jenssen, Guttorm; Gravendeel, Joost; Iversen, Bjarne Magnus. 
Akutt nyresvikt, nyrearteriestenose og angiotensinkonvertase (ACE)-hemmer.Tidsskrift for Den norske lægeforening 2001 ;Volum 121.(15) s. 1784-1788
ϳԹԴ

Svarstad, Einar; Myking, Ole Langeland; Ofstad, Jarle; Iversen, Bjarne Magnus. 
Sympathetic nervous system overactivity in hypertensive patients with chronic renal failure. Role of upright body position. Scandinavian Journal of Urology and Nephrology2001 ;Volum 35. s. 393-400
ϳԹԴ

Svarstad, Einar. 
ACE-hemmere og nyresvikt. Vårmøte Norsk Nyremedisinsk Forening; 2001-06-07
ϳԹԴ

Svarstad, Einar. 
Akutt nyresvikt, epidemiologi og nyreerstattende behandling. Grunnkurs anestesiologi; 2001-05-11
ϳԹԴ

Svarstad, Einar. 
Akutt nyresvikt (forekomst, diagnostikk, dialyseindikasjon). Grunnkurs i nyresykdommer; 2001-11-07
ϳԹԴ

Svarstad, Einar. 
Renal hemodynamics in ambulatory patients with chronic renal disease. : Universitetet i Bergen 2001 Dr.med.
ϳԹԴ

Svarstad, Einar. 
Ultralyd og Doppler av nyrer. Grunnkurs i gastroenterologisk ultralyd; 2001-11-20
ϳԹԴ

 Svarstad, Einar; Sundal, E.. 
A simplified therapy regimen with epoetin alfa is sufficient in most HD-patients. ASN; 2001-10-14 - 2001-10-17
ϳԹԴ

Vikse, Bjørn E; Aasarød, Knut Ivar; Bostad, Leif; Iversen, Bjarne M.. 
Clinical prognostic factors in patients with membranoproliferative glomerulonephritis (MPG) and benign nephrosclerosis (BN). Journal of the American Society of Nephrology2001 ;Volum 12. s. 128A-
ϳԹԴ

2000

Christiansen, Rolf EF; Roald, Anca B; Tenstad, Olav; Iversen, Bjarne M. 
Renal Hemodynamics in Young Spontaneously Hypertensive Rats (SHR) during Development of Hypertension. Journal of the American Society of Nephrology 2000 ;Volum 11. s. 332A-
ϳԹԴ

Forslund, Terje; Iversen, Bjarne M. 
Akvaporiner. Tidsskrift for Den norske lægeforening 2000 ;Volum 120. s. 2129-2134
ϳԹԴ

Kvam, Fred I; Ofstad, Jarle; Iversen, Bjarne M. 
Effect of NO-inhibition in SHR with nefron loss. Kidney and Blood Pressure Research2000 ;Volum 23. s. 376-384
ϳԹԴ

Vågnes, Øyvind; Feng, Jian J.; Iversen, Bjarne Magnus; Arendshorst, William J.. 
Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension. American Journal of Physiology - Renal Physiology 2000 ;Volum 278.(6) s. F940-F948
ϳԹԴ

People

Group manager

Øystein Solberg Eikrem Associate Professor

Contact

Mailing address:
Department of Clinical Medicine
The Laboratory Building
Haukeland University Hospital
5021 Bergen
NORWAY



Visiting address:
Department of Clinical Medicine
The laboratory building, 7th floor
Haukeland University Hospital
5021 Bergen

Emails
oystein.eikrem@uib.no